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Abstract
Background: In resource-poor settings, otorrhoea, otitis media (OM) and bacterial 
meningitis (BM) cause substantial morbidity and mortality in children. Chronic otor-
rhoea causes disabling hearing impairment (HI) and may progress into intracranial 
infections, such as BM. In order to treat middle-ear infections, knowledge of the caus-
ative agents is crucial in Africa, where limited data are available. Additionally, little is 
known about the contribution of OM to BM, the effects of a bacterial aetiology and 
the prognostic value of an auditory brainstem response (ABR) on disease outcomes 
in resource-poor settings, where childhood BM often kills or leaves survivors with 
disabling and severe sequelae.
Patients and methods: This thesis includes four different studies. The first study 
investigated the microbiology of otorrhoea samples from children 0 to 15 years of 
age between 2008 and 2015 from Luanda, Angola in a laboratory-based retrospective 
set-up and reviewed the related literature among African children over a two-decade 
period. 
A randomised treatment trial of 723 children with BM in Luanda, Angola, between 
2005 and 2008 served as the basis to study ear- and auditory-related outcomes of 
childhood BM in subsequent observational studies. The second study investigated the 
frequency and effect of OM on the disease presentation, course and outcomes. The 
third study examined the relationship between different bacterial aetiologies and the 
age at hearing outcomes.  And, finally, the fourth study examined the predictive value 
of the auditory brainstem response (ABR) on the adverse outcomes, and analysed the 
changes of ABR in childhood BM.  
9Otorrhoea & ear- and auditory-related 
outcomes of bacterial meningitis
Results: Otorrhoea in Luanda was caused by 32 different bacteria, the majority being 
Gram-negative organisms (85%). Current treatment quidelines appear locally applica-
ble, since resistance to quinolones remained rare. However, among Enterobacteriaceae 
and Staphylococcus aureus, considerable resistance was noted. Furthermore, the liter-
ature review showed a high occurrence of otorrhoea and chronic suppurative otitis 
media (CSOM) in African children as well as possible gaps in existing knowledge. 
Among children with BM, OM occurred in 12%, of which the majority was otorrhoea. 
OM in Angola served as a marker for a more complex presentation, clinical course 
and outcome of BM. Multivariate analysis indicated that OM significantly increased 
the odds of dying or complicated clinical course. Furthermore, otorrhoea was associ-
ated with HIV positivity and poor socioeconomic conditions among infants.
HI was a common sequela of BM, given that 12.8% of survivors became deaf, 6% expe-
rienced severe HI and 9% moderate HI. The effect of causative agents was significant 
only when hearing in both ears was analysed. Meningococcal meningitis caused less 
HI of any degree compared to other aetiologies (22% vs. 45%). In the age-group anal-
ysis (children <12 months of age), Streptococcus pneumoniae caused more deafness 
than other infectious agents (31% vs. 12%).
Finally, we found no predictive value using either a single or repeated ABR measure-
ment to predict death or to predict death or severe neurological sequelae. At the group 
level, the neural conduction time was prolonged in BM compared to controls. Howev-
er, due to the low specificity and sensitivity in our sample, prolongation does not serve 
as a prognostic tool. 
Conclusions: Antimicrobial susceptibility patterns support the current World 
Health Organization (WHO) guidelines for treating otorrhoea, which, in Africa, ap-
pears highly common, clearly implicating public health practises. In Angola, associ-
ated OM complicated BM, and otorrhoea served as a potential marker for HIV. The 
extent of HI appears to depend upon various factors, among which bacterial aetiology 
seems to play a role.  We continue to need prognostic tools for BM, which are appro-
priate to resource-poor settings.
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Yhteenveto
Taustaa: Matalan toimeentulon maissa korvan märkävuoto, välikorvatulehdukset ja 
märkäinen aivokalvontulehdus aiheuttavat huomattavaa sairastavuutta ja kuolleisuut-
ta lapsilla. Pitkään jatkuva korvavuoto vaurioittaa kuuloa ja voi levitä kallonsisäiseksi 
tulehdukseksi muun muassa aivokalvoihin. Jotta välikorvatulehduksia voidaan tehok-
kaasti hoitaa, tieto niiden aiheuttajista on tärkeää – erityisesti Afrikassa, jossa tietoa 
taudinaiheuttajista ja antibioottiherkkyyksistä lapsilla on vain vähän saatavilla. Lisäksi 
lasten aivokalvontulehduksen taudinkulkuun ja ennusteeseen vaikuttavista tekijöis-
tä tiedetään vähän, erityisesti köyhimmissä maissa, joissa aivokalvontulehdus johtaa 
usein kuolemaan tai vammauttaa pysyvästi huomattavan osan henkiin jääneistä. 
Potilaat ja menetelmät: Tämä tutkimus koostui neljästä osatyöstä, ja selvitti 1) 
korvan märkävuodon mikrobiologiaa 0–15-vuotiailta lapsilta Luandassa, Angolassa 
vuosina 2008-2015 otetuista näytteistä retrospektiivisessä tutkimusasetelmassa. Li-
säksi kirjallisuuskatsauksessa käytiin läpi afrikkalaislapsilla asiasta tehdyt tutkimukset 
kahden edeltävän vuosikymmenen ajalta. 
Vuosina 2005-2008 toteutettu laaja aivokalvontulehduksen hoitotutkimus 0-13 vuo-
tiailla lapsilla toimi tutkimusaineistona jatkotutkimuksillemme. Näissä tutkimuksissa 
selvitettiin 2) liitännäisen korvatulehduksen vaikutusta aivokalvontulehdukseen; 3) 
taudinaiheuttajan ja iän suhdetta aivokalvontulehduksen aiheuttamaan kuulovikaan; 
sekä 4) kuuloradan herätepotentiaalien muutoksia ja ennustearvoa aivokalvontuleh-
duksen ennusteeseen.
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Tulokset: Korvan märkävuotoa aiheutti 32 eri bakteeria, joista suurin osa oli 
Gram-negatiivisia bakteereita (85%). Ajankohtainen hoitosuositus krooniselle vuo-
tavalle korvatulehdukselle on Luandassa edelleen käypä, sillä fluorokinolonien an-
tibioottiresistenssi oli harvinaista. Enterobakteerien sekä Staphylococcus aureus –
bakteerien osalta todettiin antibioottiresistenssiä. Kirjallisuuskatsauksessa todettiin 
korvan märkävuodon ja kroonisen märkäisen korvatulehduksen olevan afrikkalais-
lapsilla hyvin yleisiä. Samalla havaittiin myös, että näistä sairauksista oli vain vähän 
tietoa afrikkalaislasten keskuudessa.
 
Aivokalvontulehdukseen sairastuneista lapsista 12%:lla todettiin liitännäinen korva-
tulehdus, josta suurin osa oli korvan märkävuotoa. Angolassa korvatulehdus liittyi ai-
vokalvontulehduksen hankalampaan taudinkuvaan, taudin kulkuun ja ennusteeseen. 
Korvatulehdus lisäsi kuoleman tai hankalan taudinkuvan riskiä monimuuttuja-ana-
lyysissä. Lisäksi lapsilla, joilla oli korvan märkävuotoa, esiintyi enemmän HIV-in-
fektiota, ja alle vuoden ikäisistä märkävuotoa esiintyi enemmän lapsilla, jotka olivat 
köyhimmistä olosuhteista.
Kuulovika oli yleinen aivokalvontulehduksen komplikaatio: 12,8% lapsista kuuroutui, 
6% sai vakavan ja 9% keskivaikean kuulovian. Taudinaiheuttajan vaikutus kuulovauri-
oon oli merkitsevä ainoastaan, kun molempien korvien kuulo analysoitiin. Meningo-
kokin aiheuttamassa aivokalvontulehduksessa kuulovikaa esiintyi vähemmän verrat-
tuna muihin taudinaiheuttajiin (22% vs. 45%). Kun iän vaikutus otettiin huomioon, 
alle vuoden ikäisillä lapsilla Streptococcus pneumoniae aiheutti kuuroutta jopa 31%:lla.
Yksittäisen tai toistetun aivorunkoherätevastemittauksen avulla ei pystytty ennus-
tamaan kuolemaa tai vakavaa neurologista vammautumista. Kaiken kaikkiaan ai-
vorungon kuuloradan johtuminen oli hitaampaa potilailla verrattuna terveisiin 
kontrolleihin. Koska sensitiivisyys ja spesifisyys suhteessa kuolemaan tai vakavaan 
vammautumiseen olivat  matalia, johtumisaikojen pidentyminen potilailla ei soveltu-
nut taudin ennusteen arvioimiseen. 
Johtopäätelmät: Antibioottiherkkyysanalyysien tulokset tukevat ajankohtaisia 
Maailman terveysjärjestön hoitosuosituksia kroonisen märkäisen välikorvatulehduk-
sen hoidossa. Korvan märkävuoto on Afrikassa hyvin yleistä ja vaatii kansanterve-
ydellisiä toimia. Angolassa korvatulehdus komplisoi bakteerimeningiittiä, ja korvan 
märkävuoto voi viitata HIV-infektioon. Kuulovika aivokalvontulehduksessa liittyy 
moniin tekijöihin,  mm. taudinaiheuttajaan ja lapsen ikään. Aivokalvontulehduksen 
ennusteen arvioimiseksi erityisesti köyhimmissä maissa tarvitaan lisää työkaluja. 
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Resumo
Circunstâncias: Em condições de baixa-renda, a otorréia, otite média (OM) e me-
ningite bacteriana (MB) causam mortalidade substancial e especialmente em crianças. 
A otorréia crônica causa perda auditiva desabilitante e pode progredir a infecções in-
tracranianas, como a MB. Para tratar as infecções de ouvido médio, o conhecimento de 
agentes causais é crucial na África, onde há disponibilidade limitada de dados. Além 
disto, conhece-se pouco sobre a contribuição da OM à MB, efeitos da etiologia bacte-
riana e o valor prognóstico da resposta auditiva do tronco cerebral (RATC) às conse-
quências de doenças em condições carentes, onde a MB infantil geralmente mata ou 
deixa os sobreviventes com sequelas severas e desabilitantes.
Pacientes e métodos: Este estudo investiga, em primeiro lugar, amostras  micro-
biológicas da otorréia de crianças de 0 a 15 anos de idade, entre 2008 e 2015 de Luan-
da, Angola, em condições retrospectivas de laboratório, assim como por uma revisão 
literária relacionada sobre crianças africanas por um período de duas décadas. 
Um estudo randomizado de tratamento de 723 crianças com MB em Luanda, Angola, 
entre 2005 e 2008, serviu como base para a pesquisa de consequências otológicas e 
auditivas da MB infantil  aos estudos de observação subsequentes. Em Segundo lugar, 
esta tese investiga adicionalmente a frequência e o efeito da OM no quadro, evolução e 
consequências da doença. Em terceiro lugar, a tese examina a relação entre diferentes 
etiologias bacterianas e a idade nas consequências auditivas.  E finalmente, exami-
namos ainda o valor prognóstico da resposta auditiva do tronco cerebral (RATC) às 
consequências adversas, assim como analisou-se ainda as alterações da RATC no MB 
infantil.  
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Resultados: A otorréia em Luanda era causada por 32 bactérias diferentes, sendo a 
maioria organismos Gram-negativos (85%). Os guias de tratamento atuais são aparen-
temente localmente aplicáveis pela rara resistência às quinolonas. Porém, resistência 
considerável entre Enterobacteriaceae e Staphylococcus aureus foi observada. Além 
disto, a revisão da literatura mostrou uma alta ocorrência de otorréia e otite media 
crónica supurativa (OMCS) nas crianças africanas, assim como possíveis lacunas no 
conhecimento existente.  
Entre as crianças com MB, a OM occorreu em 12%, a maioria dos quais com otorréia. 
A OM em Angola serviu como uma marcadora para um quadro, evolução clínica e 
consequência mais complexa da MB. A análise multivariada  indicou que a OM au-
mentava significativamente a mortalidade ou uma evolução clínica complicada. Além 
disto, a otorréia foi associada com a VIH positividade e condição sôcio-econômica 
vulnerável entre as crianças.
A perda auditiva foi uma sequela comum da MB, sendo que 12.8% dos sobreviventes 
ensurdeceram, 6% tiveram uma séria perda auditiva e 9% uma perda auditiva mode-
rada. O agente de efeito causal foi significativo apenas quando a audição em ambos 
os ouvidos foi analisada. A Meningite meningococal causou menos perda auditiva 
de qualquer grau, comparado a outras etiologias (22% vs. 45%). Na análise de grupo 
etário  (crianças <12 mêses de idade), a Streptococcus pneumoniae causou mais surdez 
do que outros agentes infecciosos (31% vs. 12%).
Finalmente, não encontramos um valor previsível usando a medição unitária  ou re-
petida de RATC para prever a morte ou uma sequela neurológica severa.  Ao nível de 
grupo, o tempo de conducção neural foi prolongada na MB ao comparado com os 
controles. Entretanto, devido à baixa especificidade e sensibilidade na nossa amostra, 
o prolongamento não serve como uma ferramenta prognôstica. 
Conclusões: Os padrões de suscetibilidade antimicrobiana apoiam as diretrizes das 
guias atuais da Organização Mundial da Saúde (OMS) para o tratamento da otorréia, 
cuja ocorrência é comum na África, com claras   implicaões às práticas de saúde pú-
blica. A OM associada complicava a MB e a otorréia serviu com uma marcadora po-
tencial para VIH em Angola. A extensão da perda auditiva parece depender de vários 
fatores, entre os quais a etiologia bacteriana desempenha um papel aparente. Ainda 
há necessidade às ferramentas prognósticas da MB mais apropriadas às condições ca-
rentes em recursos.
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1. Introduction
Otorrhoea – typically a sign of acute or chronic otitis 
media (OM) – causes substantial morbidity in chil-
dren worldwide. In resource-poor settings, it is often 
indicative of a chronic middle-ear infection leading 
to disabling hearing impairment (HI) and represents 
a risk factor for intracranial complications, such as 
bacterial meningitis (BM).1 Most of the burden of 
OM-related complications occurs in children in re-
source-poor settings.2 
BM is an infection of early childhood, which in 
Africa kills up to half of all infected children, while 
almost one-quarter are left with severe complica-
tions.3,4 While the global incidence of BM is decreas-
ing, children in low- and middle-income countries 
(LMICs) carry a substantial portion of the global 
burden of BM.5 
In order to efficiently treat otorrhoea and mid-
dle-ear infections, knowledge of the causative agents 
and their antimicrobial surveillance remain crucial. 
Studying BM among children, who represent the 
majority affected by the disease globally, may im-
prove knowledge related to preventing and treating 
the disease as well as its complications in the future. 
Many aspects of BM in resource-limited settings re-
main poorly understood. 
This study sought to assess otorrhoea, and ear- 
and auditory-related outcomes of childhood BM in 
Luanda, Angola.  We investigated the microbiology 
of childhood otorrhoea in Luanda and reviewed 
the related literature among African children over 
a two-decade period. We further characterised 
OM-associated BM, and assessed the effect of OM 
on the course and outcomes of the disease.  Further-
more, we sought to analyse the frequency of HI in 
different bacterial aetiologies of BM and the effect 
of age on HI. Finally, we assessed the predictive value 
of and changes to the auditory brainstem response 
(ABR) on the outcome of BM. 
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2.  Review of the literature
Angola is a vast country situated in the southwest of 
Africa belonging to the Central African Region in the 
World Health Organization’s (WHO) categorisation 
(Figure 1). With its long Atlantic coastline, and its 
central plateau, Angola is one of the largest countries 
on the African continent. Angola gained indepen-
dence from Portugal following a 15-year war in 1975. 
Subsequently, a 27-year civil war ended in 2002, at 
which point the country made substantial progress 
economically, politically and in terms of general wel-
fare. Despite its oil reservoirs, of which the Angolan 
economy deeply depends, the country remains clas-
sified as a lower middle-income economy. 
During the post-civil war era, gross domestic 
product growth has decelerated to 0.7% and Ango-
la continues to face severe development challenges.6 
When examining human development indicators, 
Angola falls near or behind the averages of most 
Sub-Saharan African countries on the development 
continuum (Table 1). Amongst its population, 37% 
live under the national poverty line. The mortali-
ty rate among children under 5 years of age (U-5) 
climbed to more than 200 per 1000 live births at the 
end of the civil war, and has remained one of the 
highest globally during the last decade.
2.1 Angola country profile and global health perspectives 
Figure 1. Map of Africa showing 
 Angola, the capital Luanda, and  
the WHO African region. 
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Table 1. Angola country profile in comparison to Sub-Saharan Africa, in 2017.6-8
Angola Sub-Saharan Africa 
Demographics and economy
Population, millions 29.8 1 061
Annual population growth, % 3.3 2.7
Population aged under 15 yearsa, % 47 42
People living under the extreme poverty line of $1.90  
a dayb, %
30  41
People living under the poverty line of $3.20 a dayb, % 56 66
Gross National Income per capita, US$ 3330 1454
Gross domestic product growth, % 0.7 2.6
Health 
Life expectancy at birth, years 62 60
Under-5 mortality rate per 1000 live births 81 76 
Malnutritionc in children aged under-5, % 19 18




Primary school completion rated, % 40 70
People using internet, % 13 n/a
Mobile use per 100 45 75
aWorld Health Organization (WHO) estimates available from year 2013 for Angola,  
  and from 2008 for Sub-Saharan Africa.
bWorld Bank estimates available based on data from 2008 and 2015.
cDiagnosed as weight-for-age <–2 SDs of the WHO reference values.
dWorld Bank data available from 2010 for Angola.
N/a, not available.
The Global Burden of Disease (GBD) study is 
a standardised approach developed to measure and 
compare the health status of populations.9 As such, 
for a specific condition, it quantifies the impact of 
premature death and disability on a population. 
The standard unit, the disability-adjusted life year 
(DALY), is the sum of years of life lost (YLLs) due 
to mortality and years lived with a disability (YLDs). 
DALYs can be interpreted as gaps between a pop-
ulation's actual and their ideal health status. Annu-
ally, 31 million people develop persistent otorrhoea, 
among whom almost one-quarter are U-5 children. 
These figures represent a burden of 3.5 million DA-
LYs.10 A substantial portion is attributed to children 
living in resource-limited settings, including Africa.2 
Since bacterial meningitis (BM) is often fatal and 
disabling, its global burden accounts for more than 
25 million DALYs. Since BM affects U-5 children, 
among them BM remains one of the major contribu-
tors to DALYs—that is, sixth in children aged 1 to 12 
months and seventh in children aged 1 to 4 years.10 
Again, the majority of these children reside in LMICs. 
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2.2 Childhood otorrhoea and otitis media – African perspectives 
2.2.1  Definitions and symptoms 
Definitions
Otitis media (OM) represents a spectrum of diseases 
involving inflammation of the middle ear. In acute 
OM (AOM) acute signs and symptoms emerge and 
are detected in the middle ear together with mid-
dle-ear effusion (MEE). These include moderate or 
severe bulging of the tympanic membrane (TM) or 
milder bulging in combination with either ear pain 
or intense erythema of the TM.11 Additionally, a 
new-onset middle ear–borne otorrhoea is defined 
as AOM.11 If the infection fails to recover, a chronic 
infection results. Chronic suppurative OM (CSOM) 
refers to inflammation of the middle ear and mastoid 
air cells with chronic or intermittent suppuration 
leaking through a perforated TM. Controversy exists 
on the duration of discharge. WHO defines CSOM 
as a persistent otorrhoea of at least two weeks’ du-
ration, whilst otologists define CSOM as a longer 
duration of symptoms, lasting, for instance, more 
than three months.1,12 Many clinicians consider the 
frequently associated cholesteatoma, the growth of 
squamous epithelium, in the definition of CSOM.13,14 
Otitis media with effusion (OME) refers to a condi-
tion without signs of acute infection, with effusion in 
the middle ear, behind an intact TM. 
Otorrhoea, in comparison, is defined as dis-
charge leaking from the ear. It may originate from 
the middle ear, the mastoid, the inner ear, the intra-
cranial cavity, the external auditory canal, or from a 
combination of these sites.14 But the simplest form in 
children is typically a sign of acute or recurrent OM 
with a perforated TM or ventilation tubes. In patient 
series and cross-sectional screening studies from Af-
rica, otorrhoea is typically indicative of CSOM.15,16 In 
epidemiological modelling, OM refers to both AOM 
and CSOM.17
Symptoms
Children with OM exhibit a spectrum of symptoms. 
In AOM, recent-onset symptoms possibly overlap 
with a preceding viral respiratory tract infection.11 
Respiratory symptoms are common findings; addi-
tionally, parents often report excessive crying, rest-
less sleep, irritability, ear pain, poor appetite and a 
fever.18 Ear pain is indicated, but does not represent 
a crucial sign of AOM and the ability to localise the 
pain varies with the child’s age. The American Acad-
emy of Paediatrics considers rubbing or holding of 
the ear, a fever or a change in a child’s sleep or be-
haviour patterns indicative of ear pain.11 In Africa, 
parents’ awareness of OM remains low and they are 
unlikely to suspect it.16
If TM ruptures, AOM is thought to cause less or 
no pain, possibly contributing to not seeking care in 
resource-poor settings, even when otorrhoea per-
sists.1,16 Patients with chronic otorrhoea may, how-
ever, experience discomfort or a milder earache and 
many found the condition socially challenging.19 
Hearing impairment (HI) is a frequent symptom of 
CSOM. The term chronic in CSOM is representa-
tional. In Africa, in a cohort of young children with a 
median age <5 years, otorrhoea persisted longer than 
18 months in more than two-thirds of affected ears.20 
Subsequently, the disease often persists into adoles-
cence and young adulthood. In Africa, cholestheato-
ma is a frequent complication of CSOM occurring in 
up to 20% of chronically discharging ears.20
2.2.2  Epidemiology, risk factors  
and aetiology 
Epidemiology and risk factors
Middle-ear infections are common worldwide caus-
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ing significant morbidity in children.21 Globally, 
more than 470 million episodes of OM are estimat-
ed to occur annually, more than half of which oc-
cur in children.2,22 OM is an infection of early child-
hood, since the incidence of AOM peaks just before 
a child’s first birthday at around 8 to 13 months of 
age.23,24 Recurrent infections commonly occur, and 
more than 80% of children have had an episode of 
AOM by 3 years of age.25 CSOM typically develops 
during the first years of childhood as a consequence 
of AOM when treatment is not received or fails.12,26 
Annually, more than 7 million children U-5 develop 
CSOM.2 In Africa, many develop chronic otorrhoea 
as early as before reaching 6 months of age and con-
tinue to develop the disease at a high rate during the 
first 5 years of life.27,28 Later in childhood and during 
adolescence, CSOM may develop via OME, as sug-
gested by research from Kenya.28
While AOM commonly occurs throughout the 
world, CSOM prevalence varies greatly between 
countries. In particular, it affects individuals at a 
socioeconomic disadvantage. Thus, children living 
in resource-poor or limited settings carry a higher 
risk for chronic otorrhoea. This is thought to occur 
via several mechanisms, including poor access to 
healthcare, a diminished host immunity and an in-
creased exposure to a high bacterial load for patho-
logical organisms.29 The common denominator for 
all of these mechanisms is poverty. Awareness of the 
disease and possible complications remain poorly 
understood amongst patients and caregivers.30 Spe-
cific risk factors for persistent otorrhoea in Africa 
consist of the early onset of disease, malnutrition, 
bottlefeeding, household smoke, rural residency, 
a poor socioeconomic status, geographic distance 
from a health facility and family size.27,31
Moreover, CSOM affects certain indigenous 
populations most often. In particular, prevalence 
amongst Inuits and Australian aboriginals range 
from 14% to 30%.32,33 After the prevalence rates in 
the Pacific and Southeast Asia, the incidence esti-
mates are highest for Africa.2 In Africa, the incidence 
rates for AOM and CSOM range from 14.71 to 43.37 
per 100 and 4.79 to 7.56 per 1000, respectively, with 
the highest rates found in the Central African re-
gion, which includes Angola.2
Aetiology
In most parts of the world, the bacteria typically 
cultured in AOM-related MEE consist of Strepto-
coccus pneumoniae (S. pneumoniae), Haemophilus 
influenzae (H. influenzae) and Moraxella catarrhalis. 
In resource-poor settings Staphylococcus aureus (S. 
aureus) occurs frequently, while in Africa, Moraxel-
la catarrhalis is rarely found.34,35 In a South African 
study, when samples were taken via tympanocente-
sis, the main bacterial isolates consisted of H. influ-
enzae, S. pneumoniae and S. aureus.34
In CSOM, the inflammation of the middle 
ear persists, bacteria from the ear canal colonise 
in the middle-ear mucosa and the prevalence of 
Gram-negative bacteria increases. CSOM patho-
gens may also enter the middle ear via contam-
inated water.36 Pseudomonas spp. and S. aureus 
represent the most frequent organisms followed by 
other Gram-negative species.12,26 In addition, anaer-
obs such as Bacteroides spp. and Fusobacterium spp. 
are frequently detected.26 The bacterial aetiologies 
of CSOM were thought to be relatively similar be-
tween resource-limited and affluent settings.29 How-
ever, variations between populations and geograph-
ic settings appear to play some role. For example, 
a study among school children and young adults 
from Kenya found Proteus and Enterococcus spp. in 
most of the cases.37 Furthermore, a young age may 
predispose an individual to different aetiologies. 
For instance in Africa Proteus is frequently detect-
ed in young children.37,38 Immunosuppression may 
additionally affect the causative agents of CSOM. 
For instance, Proteus mirabilis associated with anae-
mia in South Africa.39 Yet, no significant difference 
has been found when comparing HIV-positive and 
HIV-negative children. 
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2.2.3    Diagnosis and management in 
resource-poor settings
Diagnosis
The acute onset of symptoms is a key feature in the 
diagnosis of AOM.11 To confirm the diagnosis, pneu-
matic otoscopy is decisive, revealing signs of mid-
dle-ear infection and effusion behind TM: that is, a 
moderate to severe bulging position, limited or ab-
sent motility, or otorrhoea originating from the mid-
dle ear.11 In addition, milder bulging combined with 
pain or intense erythema on TM indicates AOM.11 
Tympanometry can be used to detect MEE. Other 
diagnostic measures consist of evidence of otorrhoea 
on tympanocentesis or myringotomy. In CSOM, 
otoscopy reveals red and inflamed or thickened mu-
cosa with or without the presence of discharge leak-
ing from the middle ear through a visualised perfo-
ration.1,40 The duration of otorrhoea differentiates the 
chronic form of OM from acute cases.1 CSOM may 
manifest through inactive phases when only mid-
dle-ear mucosa is inflamed, and discharge is missing 
or minimal.40 Dry perforation with healthy mid-
dle-ear mucosa is not suggestive of CSOM.
Nonsurgical Treatment 
Despite the large number of treatment trials for 
AOM, optimal treatment — particularly in high-in-
come countries (HICs) — remains somewhat contro-
versial, resulting in a variety of guidelines. Sufficient 
pain relief represents an important part of treatment. 
Yet, with regards to antimicrobials, for instance, the 
Swedish national guidelines recommend watchful 
waiting for children between 1 and 12 years of age 
in uncomplicated AOM and antimicrobial treatment 
for bilateral AOM in children under the age of 2 years 
old and for all individuals with perforated TM.41 By 
contrast, Finnish national guidelines primarily rec-
ommend antimicrobial treatment when diagnosis 
is confirmed. It appears that children under the age 
of 3 years benefit from antimicrobial treatment.42 In 
resource-poor settings, however, prompt antimicro-
bial therapy for AOM is recommended, since un-
treated ear infections carry the risk of severe compli-
cations, death and disability.43 No evidence exists on 
the safety of withholding treatment for AOM using 
antibiotics in resource-poor settings.43
If a persistent otorrhoea develops, the primary 
therapy consists of aural toileting and topical anti-
microbials.26 Aural toileting refers to ear cleansing 
with mobbing, dry wicking, flushing or suctioning, 
all aimed at keeping the ear canal clean and dry.40 No 
consensus exists, however, on the interval of ear cle-
ansing in children.26 WHO recommends antimicro-
bial use combined with dry wicking, specifically re-
lying on topical quinolone administered three times 
daily for two weeks.43 In children, topical quinolones 
appear effective in clearing up the discharge in the 
short-term.44-46 Additionally, quinolones may fa-
vourably affect hearing, although evidence on long-
term hearing outcomes and on the healing of a TM 
perforation remains lacking.47 The effect of topical 
quinolones has been demonstrated in Africa, speci-
fically in Gambia and in Malawi.44,48 A review of OM 
among Australian indigenous populations conclu-
ded, that swimming played no role in the treatment 
or management of CSOM.33 In Africa, however, no 
such research exists. With large perforations, pre-
venting contaminated water from entering the ear is 
recommendable.
In the absence of evidence, WHO recommends 
avoiding the use of topical antiseptics and steroids to 
treat chronic otorrhoea in children.43 The evidence 
favours the use of topical antimicrobials over anti-
septics.43 Of steroids utility, little is known in chil-
dren.43 In addition, first-line oral treatment does 
not appear to be more efficient than topical treat-
ment.49 In the absence of any medical treatment 
modalities, ear cleansing may carry some benefit.46 
Several recent structured review protocols have been 
published lately, to evaluate the effectiveness of al-
ternatives consisting of nonsurgical treatment of 
CSOM.50-53 
Furthermore, systemic antibiotics should be re-
served for situations where the first-line treatment 
of chronic otorrhoea fails.26 The cultivation of ear 
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pus and antimicrobial sensitivity analyses should 
guide the choice of drug.26 As the option of last re-
sort, parenteral antibiotics can be used since they 
have successfully treated chronic otorrhoea.26,47 
Ceftazidime has proved effective in treating P. aeru-
ginosa.54 Yet, again, parenteral treatment should be 
culture-directed. Intravenous treatment is indicat-
ed in cases of ICCs.26
We must recall, however, that with persistent 
otorrhoea, in particular, underlying conditions and 
comorbidities are common. For instance, HIV, tu-
berculosis, anaemia and malnutrition occur more 
often in children with otorrhoea in comparison to 
the general population.20,55-57 Moreover, HIV prev-
alence amongst children with persistent otorrhoea 
appears strikingly high: 54% in South Africa and 
64% in Angola.20,56 Thus, a child with otorrhoea in 
a resource-poor setting should always be examined 
thoroughly.
Surgical treatment
Surgical treatment is warranted in cases where med-
ical treatment persistently fails, if choleasteatoma ac-
companies CSOM and when complications occur.26 
The objectives of surgery consist of TM repair, the 
eradication of the infection or both. Tympanoplasty 
(type 1, myringoplasty), defined, as the closure of the 
tympanic perforation with a connective tissue graft, 
is the procedure indicated in noncholesteatomous 
CSOM and in cases without infectious complica-
tions. Furthermore, a combined reconstruction of 
the ossicular chain may be indicative (tympanoplas-
ty, types 2 and upward). 
Mastoidectomy, the opening of the mastoid air 
cells and the surgical removal of mucosa, granula-
tion tissue and debris, is considered when tympano-
plasty fails, in cases with a persistent infection due 
to antimicrobial resistance and in cases of infectious 
complications.58 Procedures in Nigeria include in-
cision and drainage of the subperiosteal mastoid 
abscess, cortical mastoidectomy, radical mastoid-
ectomy, myringoplasty and aural polypectomy.59 In 
2013 in Nigeria, however, tympanoplasty (type 1) 
was only available at 18% of the institutions offering 
ear surgery.19
2.2.4   Consequences 
Hearing impairment
The complications associated with OM are classi-
fied as intratemporal (extracranial) and intracranial 
complications. HI stands as the most common com-
plication and consequence of OM. In AOM, MEE is 
present, typically resulting in mild, conductive and 
transient HI. In CSOM, HI can be conductive due 
to chronic perforation of TM and disruption of ossi-
cles assembly; sensorineural due to hair cell damage 
because of invaded bacterial infection to inner ear; 
or a mixture of conductive and sensorineural HI.1 
Childhood CSOM-induced HI is associated with HI 
in adulthood.60
No consensus exists on defining the degree of 
HI.61 However, classification into four groups accord-
ing to the severity of HI in the better-hearing ear is 
common.61,62 The degree of HI in the better-hearing 
ear is defined by calculating the average of the pure-
tone thresholds over a certain frequency range.61,62 In 
children, the term disabling hearing impairment can 
be used in case of average thresholds >30 dB in the 
better-hearing ear.61 Table 2 summarises the WHO 
working group and European Union expert group 
grading for HI in children.61-63
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Table 2.  World Health Organization (WHO) working group and European Union (EU) ex-
pert group grading for hearing impairment. Adapted from previously published data.61-63 
Grade                     dB rangea Description – Performance
WHO EU
No hearing impairment ≤25 <20 No or slight problems – Able to hear whispers.
Slight / Mild 26–40 20–39 Trouble in hearing and understanding soft 
speech, speech from a distance or speech in a 
noisy environment – Able to hear and repeat 
words in normal voice at 1 metre.
Moderate 41b–60 40–69 Difficulty in hearing normal speech – Able to 
hear and repeat words in raised voice.
Severe 61–80 70–94 Only able to hear very loud speech / sounds – 
Able to hear some words shouted into better 
ear.
Profound ≥81 ≥95 Perceives loud sounds as vibrations – Unable to 
hear a shouted voice.
In South Africa, 68% of CSOM-affected ears showed 
a HI of >25 dB, of which 31% was severe to pro-
found.39 In Sub-Saharan Africa, excluding the south-
ern WHO region, the prevalence of permanent 
OM-related HI with a hearing level of >25 dB in 
the better-hearing ear varies from 0.30% to 0.34%.2 
Higher prevalences have been reported only for 
South Asia and Oceania. Amongst children U-5, 
permanent OM-related HI affects 1.92 to 2.21 in 
1000 children in Sub-Saharan Africa, while in West-
ern Europe only 0.056 in 1000 children are affected.2 
Recent WHO estimates from 2018 are consistent 
with these figures although somewhat higher. Dis-
abling HI occurs in 1.9% of children in Sub-Saha-
ran Africa: amongst those affected, 60% result from 
preventable causes and 31% due to infections.64 In 
a review of HI in Africa, 36% was attributable to 
middle-ear diseases.65 Furthermore in Africa OM has 
become the leading cause of acquired, avoidable HI 
in children.65 Amongst school-aged children, a me-
dian of 7.7% suffered from HI of >25 dB in the bet-
ter-hearing ear and a median of 6.6% experienced 
a HI of >30 dB in the better-hearing ear. These fig-
ures are much higher than previously presented es-
timates, suggesting that HI in Africa remains under-
estimated. In African settings, a history of childhood 
otorrhoea associates with HI later in school ages, 
even when the middle-ear infections were success-
fully healed at the time of evaluation.28 
Other extracranial and intracranial 
complications
TM perforation and CSOM can be classified as com-
plications of AOM. Other complications, limited to 
the middle and external ear, include adhesive otitis 
media, atelectasis of the middle ear, cholesteatoma, 
cholesterol granuloma and external otitis, while oth-
er suppurative intratemporal complications of OM 
include mastoiditis, facial nerve paresis, petrositis 
and labyrinthitis.14 In addition, vestibular, balance 
and motor dysfunctions may follow OM.13 Other 
complications occurring outside the temporal bone 
aAverage hearing thresholds for 500, 1000, 2000 and 4000 Hz in the better-hearing ear.  
bA hearing impairment of >30 dB in the better-hearing ear is classified as moderate or 
disabling hearing impairment in children <15 years. 
26 Otorrhoea & ear- and auditory-related  
outcomes of bacterial meningitis
consist of a subperiosteal abscess and a Bezold’s ab-
scess. Intracranial complications (ICCs) of OM in-
clude BM, dural venous sinus thrombosis, epidural 
abscess, subdural empyema, intracranial abscess and 
otitic hydrocephalus.13
Mortality
Globally, mortality due to OM is predominantly 
mediated through CSOM and related to ICCs.1 The 
ICC rate of 0.47% for CSOM has remained steady, re-
gardless of the decrease in CSOM from a Taiwanese 
study.66 Whilst limited data for children are available, 
this figure is used in the epidemiological modelling 
of infectious complications associated with OM.17 In 
a global review, the OM-related mortality estimates 
were calculated, which in Africa were highest for 
the Central African region, where OM is estimated 
to account for 96.20 annual deaths per 10 million 
population, with the highest mortality rates found 
amongst children U-5.2 In Angola, these projections 
account for 277 deaths, with a significant proportion 
occurring amongst children. 
Other consequences
OM represents the primary reason for prescribing 
antimicrobias to children.21 The excessive use of anti-
microbials leads to antimicrobial resistance.67 This is 
also a concern in many LMICs, where uncontrolled 
or inadequate antibiotic consumption frequently oc-
cur.21  
Few datasets provide insights into the long-
term consequences of CSOM. A follow-up cohort 
from a high-prevalence population — in this case, 
Greenland — showed that CSOM in childhood as-
sociated with a high risk of middle-ear problems 
later in adulthood.68 With highly persistent disease, 
the complication risk accumulates and the need for 
surgical interventions increases. In LMICs where 
CSOM incidence remains high, the disease remains 
long-lasting and the related HI is often disabling, 
the long-term effects are likely.1 OM-related HI may 
cause speech, language and developmental challeng-
es amongst young children. This will possibly later 
affect their academic performance.69
Because OM represents one of the most com-
mon childhood bacterial infections, its care should 
be optimised. Many cost-effectiveness and cost-util-
ity analyses of interventions are available from 
HICs.70,71 Yet, similar African data remain scarce.1 
However, different CSOM treatment strategies 
aimed at preventing OM-related HI have been ex-
amined, whereby aural toileting in combination 
with topical antimicrobials emerged as the most ef-
fective intervention.72 
2.2.5   Studies from Africa
A literature search identified prospective studies fo-
cusing on or comprehensively presenting findings 
for different types of OM in children and adolescents 
between 2008 and 2018 (Tables 3 & 4). Table 3 sum-
marises population-based or large cross-sectional 
studies16,28,37,69,73-75 and patient series,15,57,76-80 while Ta-
ble 4 displays the aetiological studies.34,37,39,56,81,82 
Table 3. Otitis media in African 
children and adolescents in pro-
spective studies, 2008 to 2018. 
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Literature search from October 2018. Percentages are isolates per ears. Data for U-5 stands for  
extractable numerical data from text, figures or tables for children under the age of 5 years.  
AOM, acute otitis media; CSOM, chronic suppurative otitis media.
 
2.3 Childhood bacterial meningitis — African perspectives
2.3.1  Definition and symptoms
Bacterial meningitis (BM) is an infection affecting 
the membranes surrounding the brain and spinal 
cord, and cerebrospinal fluid (CSF) in the subarach-
noid space and ventricles. The infection may mani-
fest in the form of a classic triad of symptoms—that 
is, fever, neck stiffness and an altered mental status. 
However, young children often exhibit nonspecific 
symptoms, sometimes only manifesting as irrita-
bility, lethargy or poor eating.83 The symptoms of 
increased intracranial pressure (ICP) may appear, 
as well as focal neurological signs, ataxia and be-
havioural abnormalities. Seizures are common 
whereby almost half of the individuals affected by 
BM exhibit them upon presentation.84 Sometimes 
petechial skin lesions develop, but they primarily 
associate with Neisseria meningitidis (N. meningit-
idis).85  
In addition, BM may develop progressively over 
several days, or it may appear with a quick onset of 
symptoms leading to sepsis and meningitis within 
a couple of hours. Associated sepsis is common, al-
though meningitis may also manifest as an isolated 
Table 4.  Prospective studies on the bacterial aetiology of different types of otitis 
media in children and adolescents in Africa, 2008 to 2018.
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infection. Nevertheless and despite effective antimi-
crobial treatment and advances in critical care, the 
disease is life-threatening and often results in dis-
abling sequelae. 
2.3.2 Epidemiology, risk factors  
and aetiology
Epidemiology and risk factors
BM in particular, is an infection of early childhood, 
with the highest incidence found during the neo-
natal period, and remaining high until the age of 2 
years. Subsequently, the disease affects children U-5 
at a higher rate than older children.86,87 After the age 
of 5 years, proportional rates for S. pneumoniae re-
main steady, while N. meningitidis increases, and 
H. influenzae type b (Hib) meningitis rarely occurs.87 
Childhood conjugate vaccines have contributed to a 
decreased incidence in recent decades, also in many 
low-income countries.88-90 Regardless of this favour-
able decline, meningitis continues to affect more 
than 2 million children annually, representing tenth 
most common cause of mortality amongst U-5 chil-
dren globally.5 
Whilst childhood BM is devastating to any child, 
the incidence, mortality and complication rates re-
main highest in the poorest regions of the world. Af-
rica faces a disproportionately large burden of global 
meningitis.91 This results from the high rate of endem-
ic BM, epidemics of BM and the young age of the pop-
ulation.92 Furthermore, incidence rates are relatively 
high across age groups. For instance, in Burkina Faso, 
S. pneumoniae meningitis incidence rates reached 
26.9/100 000 for children aged <1 year, 5.4/100 000 for 
children aged 1 to 4 years and 7.2/100 000 for children 
aged 5 to 14 years in 2013.93 n Finland between 2010 
and 2014, by contrast, S. pneumoniae incidence rates 
per 100 000 were 2.33 for children under the age of 2 
years, 0.33 for children aged 2 to 4 years and 0.05 for 
children aged 5 to 17 years.94 
High rates of immunosuppression resulting from 
various factors add to the risk of BM. Sickle-cell dis-
ease is associated with pneumococcal meningitis, 
while amongst HIV-infected individuals, the odds of 
acquiring and dying from pneumococcal meningitis 
increase.95,96 In addition to a young age and immu-
nosuppression, poor living conditions and exposure 
to pathogens predispose individuals to BM. With 
shunts, skull fractures and cochlear implants, the 
riks of BM is further elevated.83,97 
Aetiology
Although a range of bacteria can cause BM, the main 
causative agents beyond the neonatal period consist 
of S. pneumoniae, Hib and N. meningitidis. These 
bacteria have the potential to invade into the host’s 
blood stream, and resist the host’s natural defences, 
subsequently invading the central nervous system 
(CNS).83 S. pneumoniae, a Gram-positive diplococci, 
represents the leading cause of childhood BM glob-
ally.22,90 S. pneumoniae is endemic in Africa, and sea-
sonal peaks occur during the dry season.90 
In comparison, Hib, a Gram-negative coccoba-
cillus with capsular polysaccharide type b, has no-
tably decreased in countries with high vaccination 
coverage.88,90,98 In Angola, due to inefficiencies in 
vaccine implementation, which began in 2006, Hib 
meningitis continues to occur regularly albeit at a 
low rate.99 
Finally, N. meningitidis, a Gram-negative dip-
lococci, is endemic in Africa and causes epidemics. 
In resource-limited settings, Staphylococcus species, 
Gram-negative enteric basilli, and Pseudomonas aeru-
ginosa (P. aeruginosa) also cause BM in children, typ-
ically amongst the youngest ones, or amongst those 
with predisposing comorbidities and conditions.4,100 
Globally, the proportional incidence of BM caused by 
other pathogens in children U-5 is increasing.91
2.3.3 Diagnosis and management
A lumbar puncture and laboratory analysis of CSF 
are crucial for the diagnosis of BM. From the CSF, 
an analysis of white blood cells (count and differ-
30 Otorrhoea & ear- and auditory-related  
outcomes of bacterial meningitis
entiation), the glucose and protein concentrations, 
Gram stain and cultivation should be performed, 
with the latter serving as the gold standard for di-
agnosis.83 Other diagnostic tools include antigen 
detection with latex agglutination, and polymerase 
chain reaction (PCR) from CSF, which are especial-
ly valuable in cases of treatment preceding lumbar 
puncture.83 
Treatment of BM includes systemic broad-spec-
trum antimicrobials. Beyond the neonatal period, 
third-generation cephalosporines are recommend-
ed.101 In addition, adjunctive and supportive treat-
ments aim to improve survival and prevent related 
sequelae.101 In short, dexamethasone and glycerol 
have been studied, but are not routinely used in Af-
rica. Furthermore, corticosteroids provide no benefit 
in low-income countries, while a recent meta-analy-
sis states, that glycerol may carry a beneficial effect 
on neurological sequelae and deafness.102,103
2.3.4 Pathogenesis and  
pathophysiology
Following the neonatal period, the typical menin-
geal pathogens are acquired from close contacts. 
These pathogens colonise in the mucosal surfaces 
of the nasopharynx of carriers and bind to the host 
epithelial cells. The carriage rates depend on host-re-
lated and socioeconomic conditions. For instance, 
up to 63% of children U-5 in Africa carry S. pneu-
moniae.104 Viral infection typically preceeds invasion 
across the host’s epithelial structures, facilitated by 
different adhesion molecules, and in the case of S. 
pneumoniae, the phase variation of the capsule mol-
ecules.105 Once in the blood stream, the complement 
cascade is activated. The capsulated bacteria causing 
BM pose innate resistance to antibody-mediated 
opsonisation and may further penetrate into CNS.83 
Additionally, the bacteria may enter CNS from local 
infectious foci through contiguous spread.106
Bacteria are capable of crossing the blood–brain 
barrier by interacting with the host receptors in a 
complex process via inter- and intracellular trans-
cytosis.107 In CSF space, limited host defence mech-
anisms allow bacteria to rapidly multiply. In CNS, 
after pattern recognition receptors, such as Toll-like 
receptors in microglia and other antigen presenting 
cells, recognize the bacterial cell wall components, 
the host inflammatory response is initiated.105 These 
cells release proinflammatory cytokines such as tu-
mor necrosis factor-alpha and interleukines. The 
cytokines further induce the adhesion molecules on 
the local vascular endothelial cells supporting leuko-
cyte migration into CSF.107 Both the invaded neutro-
phils and endothelial cells produce reactive oxygen 
and nitrogen species, and matrix metalloproteinases 
causing blood–brain barrier permeability, further 
leukocyte recruitment and tissue damage.105,108 Anti-
biotics cause bacterial lysis, which further increases 
the inflammation. Subsequently, ICP increases. The 
cerebral blood flow is further disturbed due to the 
dysfunction in the brain vessel autoregulation and 
decrease in systemic perfusion.107 Consequently, 
neuronal injury and apoptosis occur. 
2.3.5 Studies from Africa
A literature search identified prospective studies fo-
cusing on or summarizing the outcomes of childhood 
BM in Africa between 2008 and 2018 (Table 5).109-116 
Only a limited number of studies were identi-
fied, a minority of which consisted of randomised 
controlled trials.112,114 Half of the studies focused on 
diagnostics, the prevalence of causative agents, their 
serotype distribution and antimicrobial susceptibili-
ty patterns.109,110,113,116 The effect of Hib vaccinations is 
clearly documented in these studies, with a decreas-
ing prevalence of Hib meningitis over time. Many 
of the studies lack any reporting of the neurological 
sequelae and HI; when reported, the use of differing 
methods to diagnose and classify sequelae hampered 
comparisons across studies.
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2.4 Otitis media–associated childhood bacterial meningitis
In the antimicrobial era, OM-related compli-
cations have become rare. Thus epidemiological 
calculations are based on retrospective series. In re-
source-limited settings BM was estimated to occur 
in 0.1%–0.2% of otitis media, of which majority is 
chronic.123-125 More recently, an incidence of 0.47% 
has been established for all ICCs.66 However, chil-
dren represent a minority in these studies and the 
values may not be comparable for poorest countries. 
In a recent retrospective study from India over a 15-
year period in a tertiary centre, researchers traced a 
declining number of ICCs due to CSOM, where BM 
accounted for one-quarter of all ICCs in children.126 
Cholesteatoma is a typical comorbidity in patients 
with ICCs.127
In Malawi, 46% of children with pneumococ-
cal meningitis presented with concomitant OM.128 
However, to our knowledge, no detailed analysis 
with concomitant OM on the presentation, course 
and outcome of BM is available from resource-lim-
ited settings. As certain predisposing conditions are 
important riskfactors for the disease outcomes, a 
concomitant or predisposing focus of infection may 
additionally affect illness outcomes.117,129
Bacterial meningitis (BM) normally results from the 
spread of bacteria from the bloodstream. BM may 
also directly result from invasion from adjacent sites, 
such as the middle ear and the mastoid cavity.106,117 In 
high-income settings, OM occurs in approximately 
25% of S. pneumoniae meningitis cases in children 
and up to 45% of all-cause childhood BM.117,118 Addi-
tionally, OM may co-exist or follow BM.119 
From OM, bacteria are thought to enter the CSF 
space via direct extension through dehiscences—ei-
ther those already existing or acquired dehiscences 
(e.g., weakened mastoid bone or fractures) via lab-
yrinthitis, or blood circulation.120 In congenital mal-
formations, openings between the inner ear and the 
middle ear facilitate pathogen entry from the middle 
ear to the labyrinth and, subsequently, to the CSF 
space.97 Some temporal bones from young children 
who died due to BM, indicate an otitis aetiology.121,122 
In early childhood, temporal bone studies illustrate 
that the middle ear exhibits mesenchymal connec-
tions that associate with a high rate of OM and open 
up a possible route for the haematogenous spread 
from OM to the subarachnoidal space.120 Figure 2 
provides an illustration of the anatomical structures 
of the middle ear in proximity to CNS.
2.5 The consequences of childhood bacterial meningitis
A spectrum of sequelae may follow childhood BM. 
The sequelae can be classified as severe, thus produc-
ing significant disability or less severe, resulting in 
difficulty completing everyday activities and impair-
ing one’s quality of life.132 In a global and regional me-
ta-analysis of BM, HI emerged as the most common 
severe sequelae reported in up to 34% of cases.132 
Other severe sequelae consisted of seizures (13%), 
motor deficits (12%), cognitive impairment (9%), hy-
drocephalus (7%) and visual disturbances (6%).132 In 
addition, a mixture of sequelae are common and may 
present as complex syndromes (see Figure 3).111
2.5.1 Hearing impairment 
Amongst survivors of childhood BM, 10% to 34% 
develop some degree of HI.132 BM remains an im-
portant cause of acquired HI in children since 31% 
of all childhood HI result from BM and other in-
fectious related causes.133 The risk of HI is a conse-
quence of illness-, host- and treatment-related fac-
tors.134 However, all underlying mechanisms and risk 
factors are not fully understood.  
Furthermore, BM is associated with partial or 
complete, unilateral or bilateral sensorineural HI, 
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Figure 2. Infection of the middle ear 
(ME) with otorrhoea draining through 
a perforated tympanic membrane (TM) 
to the ear canal (EC). The cerebrospinal 
fluid (CSF) appears turbid, indicating 
bacterial meningitis.v C, cochlea; CA, 
cochlear aqueduct; AN, auditory nerve; 
ET, eustachian tube. Adapted from 
previously published data.130,131 
Figure 3. An 18-month-old survivor of 
pneumococcal meningitis in Luanda, 
Angola diagnosed with tetraparesis, 
facial nerve paresis, blindness, hear-
ing impairment, seizures and severe 
mental retardation. Photo: Mariia 
Karppinen
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typically occurring early in the disease.135 Since HI 
can occur as an isolated event, independent of neu-
rological sequelae, the underlying mechanisms of 
HI and neurological sequelae are thought to differ 
somewhat.136,137 
2.5.1.1 The pathophysiology and aetiology 
of hearing impairment 
Labyrinthitis and associated HI following BM are 
well-documented, beginning from research in the 
nineteenth century.138 During the early twentieth 
century, the routes of spread of infection from the 
meninges to the inner ear via the cochlear aqueduct, 
the internal auditory canal and the vasculature were 
established.138 Histopathological studies show co-
chlear damage, bacteria and leukocyte infiltration in 
the cochlea and vestibular organs. Based on a me-
ta-analysis, the median risk of bilateral HI at the >26 
dB level is highest for S. pneumoniae with a 9.9%, 
followed by Hib with a 4.5% and N. meningitidis with 
a 4.1%.132
In animal studies, the patent cochlear aqueduct 
represents the primary pathway for infection to en-
ter to the labyrinth. The inflammatory infiltrates fill 
the perilymphatic space of the scala tympani in the 
basal turn of the cochlea, and result in gradual dam-
age along the base to the apex axis.139 Oxidative stress 
disrupts the blood–labyrinth barrier, which, in the 
acute phase, correlates with the severity of HI.119,140 
At the cochlear level, bacterial toxins and inflam-
matory reaction products, such as reactive oxygen 
species and cytokines, specifically tumor necrosis 
factor-alpha, damage the hair cells.141 The outer hair 
cells show an increased vulnerability.142 Spiral gan-
glion neuron loss subsequently occurs in the fol-
lowing weeks.119 Both the severity of infection and 
inflammation correlate with the level of HI.142 After 
infection, the connective tissue obliterates the peri-
lymphatic spaces, and fibrosis and ossification may 
follow. Long-term HI is likely caused by hair cell and 
spiral ganglion neuronal damage as well as labyrin-
thitis ossificans.119,143 To a small degree, retrocochlear 
HI following BM has been decribed in children.144 
2.5.2 Neurological sequelae 
Neurological sequelae typically develop during the 
acute illness phase, but may present as transient 
(85%) or persistent (15%) deficits following dis-
charge.137 
Symptoms likely to relieve during the first year 
post-discharge include ataxia, cranial-nerve deficits, 
extensor plantar reflexes and brisk reflexes, while 
persistent symptoms consist of severe mental retar-
dation, tetraparesis, and blindness.137 Hemiparesis 
often, although not always, improves.137 Severe cog-
nitive impairment, defined as a score of <70 intelli-
gent quotient, is frequently unreported upon hospi-
tal discharge and may be underestimated in clinical 
trials.132 In Bangladesh, significant impairment in 
mental development was diagnosed in 41% of those 
followed for 6 to 24 months post-discharge.145 The 
risk of at least one severe sequela is highest amongst 
children U-5 and in the African region compared 
to other parts of the world.132 In Africa, about one 
fifth of BM survivors develop sequelae prior to dis-
charge.4 
2.5.2.1  The pathophysiology and  
 aetiology of neurological injury
The substances released and immune-mediated host 
reactions ultimately contribute to the breakdown of 
the blood–brain barrier, oedema, increased ICP, al-
tered homeostasis and physiology of the brain, final-
ly resulting in neuronal damage, cellular apoptosis 
and variety of brain injury. Pus-filled ventricles and 
gross lesions in the brain and meninges represent 
frequent autopsy findings.146 Histopathological ex-
aminations in humans reveal intravascular coagu-
lation, vasculitis, perivascular infiltrates, ischemic, 
hemorrhagic and necrotic lesions, axonal injury, 
apoptosis in the hippocampus, and synaptic loss 
in the neocortex.105,107,147 Imaging shows ischemic 
changes in children left with permanent neurologi-
cal sequelae.137,148 In the presence of infarctions, mul-
tiple lesions commonly occur in the hemispheres, 
thalamus, basal ganglia and pontine, and associate 
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with hydrocephalus.148 Clinically diagnosed focal 
neurological deficits are commonly reported from 
large clinical trials and in Malawi they most often 
associated with pneumococcal aetiology. 84 
Animal studies reveal a proportional correlation 
between CSF inflammation, mortality and morbid-
ity.105 Bacterial toxins and excessive host inlamma-
tion, specifically the neutrophil activity with secret-
ed proteases, as well as nitric and oxygen species, 
are thought to contribute to tissue damage. Further-
more, an impaired consciousness is concidered an 
indicator of neuronal damage.114 
2.5.3 Mortality
In Africa, case-fatality rates remain high, where-
by 30% to 50% of children die before hospital dis-
charge.3,4,93 In addition, 10% of survivors die in 
the few months and years following discharge.92 
Amongst all BM-related deaths in Africa, the major-
ity occur in children.92 In the African region, death 
due to meningitis or encephalitis in children aged 
1 to 59 months has slowly decreased from 4.4% to 
3.2% between 2006 and 2016.149 In Angola, 1.1 out 
of 1000 live births die from meningitis or encepha-
litis.150 However, in Africa, these rates likely remain 
underestimated since many deaths go unrecorded 
or are interpreted as cerebral malaria. The case- 
fatality rate – that is, the proportion of individuals 
dying from the disease – is highest for pneumo-
coocal meningitis (35%) followed by Hib menin-
gitis (23%) and menincococcal meningitis (4%).132 
However, recent estimates from 2016 state that in 
children U-5, N. meningitidis and meningitis caused 
by other pathogens were responsible for most BM 
deaths globally..91   
2.5.4 Other consequences
Neuropsychological performance and executive 
functions represent domains often underevaluated 
following BM in resource-poor settings. Difficul-
ties in these functions may substantially impact be-
haviour, education, social relationships and the qual-
ity of life amongst survivors. In Senegal, survivors of 
BM required more additional assistance from parents 
with toileting, dressing and other activities of daily 
living in comparison to controls.111 In Kenya, school-
aged survivors of S. pneumoniae meningitis experi-
enced problems completing tasks requiring visual 
and auditory attention.151 Acute disease creates great 
financial burdens to families, since the mean dis-
counted lifetime costs due to BM sequelae in Senegal 
reached approximately US$ 35 000 per child.152 At the 
time of the study, none of the families could pay for 
treatment and rehabilitations for the sequelae.152
2.6 Predictors of adverse disease outcomes in  
 childhood bacterial meningitis
Predicting BM-associated outcomes may help in al-
locating resources and planning rehabilitation for 
those most in need of care. The severity of the infec-
tion is closely related to its adverse outcomes. Several 
models have been developed to predict the prognosis 
of childhood BM in terms of death, severe neurolog-
ical sequelae and auditory outcomes. However, since 
the circumstances, conditions upon presentation and 
outcomes largely differ between low- and high-in-
come countries, generalisability depends upon the 
specific setting.  From Africa, studies are scarce.153  
2.6.1 Predictors of hearing  
impairment
A systematic review identified a history of symp-
toms >48 hours, a low CSF glucose, male gender, 
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the absence of petechiae and S. pneumoniae aetiol-
ogy as risk factors for HI.154 However, only one out 
of four studies originated in resource-poor settings, 
where the risk factors somewhat differed from those 
in high-income settings. In Africa, HI associated 
with a high fever >38.7°C, coma, convulsions, as-
sociated cranial nerve neuropathy or neurological 
sequelae, a low blood leukocyte count, positive CSF 
Gram-stain or culture and a high CSF protein lev-
el.115,155 In Angola amongst a subset of a BM cohort, 
predictors of post-discharge HI were evaluated.156 
However, due to a loss of follow-up, only 124 chil-
dren were studied. Amongst these survivors, focal 
seizures emerged as the strongest predictor of HI.156
The power of these former studies from low-in-
come settings may have been limited to analysing 
the role of bacterial aetiology in further detail. In 
addition, the aetiology may play a role if milder HI 
were taken into account. 
2.6.2 Predictors of severe  
neurological sequelae
Symptoms indicating severe disease correspond to 
neurological sequelae, which in Africa are the fol-
lowing: a history of symptoms lasting more than 
three days, impaired consciousness or coma and 
convulsions during hospitalisation.114,157 In addition, 
a young age of less than 24 months, focal nerve defi-
cits, abnormal posturing and muscle tone have been 
associated with neurological sequelae.114,158 Salmonel-
la spp. and S. pneumoniae increased, while N. menin-
gitidis decreased the odds of permanent sequelae in 
Malawi.114 In other parts of the world, malnutrition, 
low blood leukocytosis, a high CSF protein level and 
symptoms lasting more than two days carry a risk for 
adverse neurological outcome.159,160 
2.6.3 Predictors of death
Factors relating to the severity of disease also appear 
to predict death.154 These include coma or impaired 
consciousness, convulsions, peripheral circulatory 
failure and severe respiratory distress.154 In addition 
to these factors, in Africa persistent convulsions 
during hospitalization, the appearance of purulent 
or turbid CSF, a positive CSF culture, a high CSF 
protein level and a low CSF glucose level associate 
with mortality.116,157,161 In Malawi, HIV positivity, 
severe malnutrition and Salmonella spp. aetiology 
have also been identified.114 In univariate analyses, 
S. pneumoniae carried a higher and N. meningitidis 
lower odds of death.114 Data from elsewhere suggest 
malnutrition increases the odds of dying.160
2.7 Auditory brainstem response
Auditory brainstem responses (ABRs) are electric 
potentials resulting from the summated activity of 
a large population of neurons in the auditory path-
way firing in synchrony after introducing sound to 
the ear. ABR is used to estimate hearing sensitivity 
and the integrity of the ascending auditory system.162 
In addition, ABR serves to study the neural develop-
ment of infants in conditions that are affecting the 
auditory pathway in brain stem.163 ABR test is non-
invasive, objective, and unaffected by anaesthetics 
or anticonvulsants, and thus particularly suitable for 
young or sick children.
The potentials are recorded using electrodes 
placed on the scalp. Background noise and biolog-
ical electric activity such as EEG-waves are filtered 
out using amplification and averaging techniques. 
By averaging more than one-thousand recordings, 
the small electric potentials occurring during 10 ms 
after stimuli can be distinguished. The waveform 
components are labelled I to VII, of which the most 
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reproducible and detectable are waves I, III and V 
(Figure 4).164 
The waveforms reflect the neural activity at dif-
ferent levels of the auditory pathway from the audi-
tory nerve to the brain stem (Figure 5). The dendritic 
cells in the VIII cranial nerve innervating the inner 
and outer hair cells of the cochlea, generate the wave 
I.165 Wave II is generated proximally in the VIII cra-
nial nerve. Wave III originates from the cochlear nu-
clei in the brain stem, while wave IV is generated in 
the superior olivary complex.165 Wave V originates in 
the lateral lemniscus and inferior colliculus.165 Sub-
sequent waves VI and VII likely originate in the in-
ferior colliculus.165 Waves II, VI and VII are typically 
too variable, while wave IV may merge with wave V. 
The maturation of a child during early life is reflect-
ed in the ABR. The latencies and interpeak latencies 
(IPLs) lengthen during the early life and reach adult 
values at approximately 18 to 24 months of age. Sub-
sequently ABR changes very little.166
Figure 4. A standard auditory brainstem response of a  
normal-hearing individual (at 63-dB stimulation level) to click- 
stimulus. Latencies I, III and V and interpeak latencies I–III, III–V  
and I–V are marked. Adapted from previously published data.167 
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Figure 5. The brain-
stem, major ascending 
auditory pathways and 
related nuclei from a 
posterior view.168 
Crossing pathways 
above superior olivary 
complex (SOC) are not 
illustrated. AN, auditory 
nerve; CN, cochlear 
nuclei; LL, lateral lem-
niscus, IC, inferior collic-
ulus; MGB, medullar 
geniculate body.
 
2.7.1 Auditory brainstem response in 
hearing evaluation
In audiology, ABR serves as an important tool in 
neonatal hearing screening and in assessing hearing 
amongst those unable to participate in tradition-
al hearing evaluations, such as young and disabled 
patients. ABR provides an estimation of the hear-
ing threshold that correlates to behavioural thresh-
olds.169 Patients are tested in a comfortable position, 
with their neck muscles relaxed since muscle activity 
causes biological noise producing an unfavourable 
signal-to-noise ratio. Natural sleep is encouraged. 
In click ABR, the click stimulus is a sound pulse 
comprised of many frequencies, typically 2000 to 
4000 Hz. The rate of clicks varies from 10 to 50 clicks 
per second. In the recording, 1000 to 2000 signals 
are averaged. Whilst stimulating one ear, the other is 
masked with a lower intensity. The stimulus intensity 
is decreased until wave V disappears; the lowest in-
tensity level producing a repeatable wave V indicates 
the estimated hearing level.
2.7.2 Other applications of audi-
tory brainstem response and 
findings from central nervous 
system infections
ABRs may provide prognostic information amongst 
comatosed patients. The stability of the recording 
associates with survival170 and the absence of typi-
cal waveforms provides a relatively high prognostic 
accuracy of an unfavorable outcome.171 The clinical 
use of ABRs nevertheless remains low and limited to 
special circumstances in high-income settings.172,173 
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In newborns with hypoxic-ischemic encephalopa-
thy, a severely abnormal ABR with distorted or abol-
ished patterns predicts an ominous outcome.174,175 
In small series examining CNS infections, ABR al-
terations correlated with death176 and brainstem le-
sions.177 Since ABR is noninvasive, relatively easy to 
perform, and successfully introduced in Luanda,178 
we rationalised analysing the usefulness of ABR in 
relation to clinical outcomes. 
Changes to ABR during CNS infections have 
been described in the literature. These changes in-
clude prolongation of latencies and IPLs in compari-
son to normative data or healthy controls in bacterial 
and tuberculous meningitis.176,179-181 A study on viral 
encephalitis noted a decerase in the V/I ratio of la-
tencies.177 A delay of latencies was also described in 
the absence of a concomitant ABR-threshold eleva-
tion.179 
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3. Aims of the study
The specific aims of this study were as follows: 
I To describe the aetiological agents, their change over time and the antibiotic 
susceptibility patterns of otorrhoea and to compare the findings with data 
obtained from a literature review on otorrhoea and chronic suppurative otitis 
media in Africa.
II To assess the occurrence and effect of associated otorrhoea and otitis media  
on the presentation, progression and outcome of bacterial meningitis.
III To assess the effect of the bacterial aetiology and patient age on hearing  
impairment in bacterial meningitis.
IV To assess the prognostic value and changes in auditory brainstem response  
in relation to the mortality and severe neurological complications in bacterial 
meningitis.
This study primarily focused on data collected amongst children in Angola.       
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4. Patients, materials and methods
4.1 Study location
This study consists of patients from the Children’s 
Hospital of Luanda, Angola. The hospital is a public 
university teaching hospital and tertiary referral centre 
providing services for children ≤15 years of age in the 
Angolan capital city Luanda. The estimated catchment 
population is 1.3 million children based on WHO pop-
ulation estimates.8 Each day, the families of approxi-
mately 300 children seek consultation at the emergen-
cy department, most without a referral. Since there is 
only one public ear, nose and throat (ENT) unit in Lu-
anda, most children with ear-related problems are ini-
tially evaluated and treated at the Children’s Hospital. 
The neuro-infectious disease ward cares for patients 
suffering from BM and other CNS infections. 
1870 presented to Luanda 
Children’s Hospital with signs and 





 1 dry perforation
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 272 died
 77 ABR not





 458 parent / guardian unaware
 of previous treatment
 397 met exclusion criteria
 229 other diagnoses
 21 were treated elsewhere
 8 died before ward
 6 refused to participate
502 excluded
 366 ABR not
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4.2 Patients and study design
In this doctoral thesis study, we included children 
who had an episode of otorrhoea and who were 
sampled for ear discharge between 2008 and 2015 
(n = 654), who were treated for bacterial meningitis 
between 2005 and 2008 (a subset of n = 723) (Fig-
ure  6),112 and who participated as voluntary con-
trols for ABR recording during the same study pe-
riod (n = 101) at the Children’s Hospital of Luanda.
We collected data in the otorrhoea and re-
view study (study I) retrospectively, whilst the 
meningitis studies (studies II–IV) consisted of 
prospective data collection. Study I included a 
literature review on OM in African children be-
tween 1997 and 2017. 
Figure 6. Flow of 
children with bacterial 
meningitis included in 
this thesis (studies II–IV). 
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4.2.1 Study and literature review of 
otorrhoea (study I)
This descriptive, observational, laboratory-based 
study combines a literature review. The study con-
sisted of 654 children, all under the age of 15 years, 
of whom 678 otorrhoea samples were taken between 
2008 and 2015. The children were both in- and out-
patients of the hospital. The causative agents, their 
change over time and the antimicrobial susceptibili-
ty were described. 
We also conducted a literature review of OM 
studies carried out amongst African children between 
1997 and July of 2017. We searched Medline, African 
Journals OnLine, African Index Medicus and Co-
chrane databases for otitis media studies consisting of 
at least 30 patients. In addition, published papers and 
reviews were manually searched for citations. We in-
cluded studies describing the prevalence or aetiologi-
Figure 7. Performing a spinal tap in Luanda, 
Angola, for a child with sauspected bacteri-
al meningitis. Photo: Tuula Pelkonen.
cal agents or both in children ≤15 years with CSOM 
or otorrhoea, regardless of language of publication. In 
addition, we included publications evaluating the bur-
den of paediatric OM in different healthcare settings.
4.2.2 Meningitis studies (studies II–IV)
The three meningitis studies (studies II–IV) are 
observational, descriptive studies. Study IV further 
includes a comparative component. Each study con-
sists of a subgroup of 723 children, aged 2 months to 
13 years, with presumptive BM treated in Children’s 
Hospital of Luanda as part of a prospective BM treat-
ment trial that took place between 18 July 2005, and 
26 June 2008 (Figure 6).112 The original trial com-
pared different methods of antibiotic delivery with 
and without adjuvant therapy, which lies beyond the 
scope of this thesis study. The data collected served 
as a basis for secondary analyses and study questions. 
4.3 Clinical and laboratory procedures 
4.3.1 Study of otorrhoea (study I)
An attending physician referred children with otor-
rhoea for laboratory sampling. Laboratory techni-
cians from the hospital microbiology laboratory 
swabbed a sample from the child’s draining ear. Ear 
pus was cultured on blood and chocolate agar plates 
and incubated in a 3% to 4% CO2 atmosphere at a 
suitable temperature for 24 to 48 hours. The bacteria 
were then identified using Gram staining and stan-
dard phenotypic bacteriological methods.  Antimi-
crobial susceptibility was tested with commercially 
available discs using standards from The Clinical & 
Laboratory Standards Institute.182 The main isolate 
and its susceptibility were noted in the laboratory 
request forms and registered in the laboratory data-
base. Discharging ears were treated according to the 
hospital guidelines.  
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4.3.2 Meningitis studies (studies II–IV)
Consecutive children presenting with impaired con-
sciousness, seizures and meningeal signs had a lum-
bar puncture collected by the attending physician 
in the hospital’s emergency room (Figure 7). When 
CSF appeared cloudy, proved positive in Gram-stain 
or latex agglutination test, or resulted in ≥50 x 106/L 
leukocytes, the child was assessed for eligibility in 
the study. Those with trauma, an intracranial shunt, 
previous neurological abnormality, immunosup-
pression not resulting from HIV or sickle-cell dis-
ease, active tuberculosis, a previous known HI or 
who received > 1 parenteral dose of antimicrobials 
were excluded from the study. 
After obtaining a signed informed consent from 
a parent or guardian, data collection began. An in-
terview detailing demographic characteristics and 
previous symptoms was carried out. On the ward, 
children were monitored by study nurses, who col-
lected data daily using separate study forms. Study 
physicians working on the ward examined each pa-
tient daily. A hearing evaluation and neurological 
evaluation were carried out at predefined timepoints. 
The principal investigator, a paediatrician, monitored 
and supervised the study throughout the project.
All children were treated following the WHO 
guidelines,183 with cefotaxime 250 mg/kg per 24 
hours for at least 7 days with difference in antibiotic 
delivery during the first 24 hours: either continuous 
infusion or boluses and adjuvant paracetamol or a 
placebo for 48 hours. All children received glycerol 
and, if needed, ibuprofen, correction for hypovole-
mia and treatment for anaemia, hypoglycaemia, sei-
zures, and malaria. 
4.3.2.1  Case definitions
BM was confirmed in a child presenting with com-
patible symptoms and signs when the CSF culture or 
PCR proved positive; a blood culture proved positive; 
or at least two of the following were fulfilled: CSF leu-
kocytes ≥100 x 106/L, positive Gram stain, positive 
latex agglutination test, or serum CRP ≥40 mg/L.
An OM diagnosis was based on pneumatic otos-
copy revealing either a suppurative secretion origi-
nating from the middle ear (otorrhoea) or middle-ear 
effusion combined with at least two of the following 
signs: decreased or absent mobility, bulging position, 
or an abnormal color or opacity of the TM.
4.3.2.2  Laboratory analyses
Following a spinal tap, CSF leukocyte and eryth-
rocyte counts were measured, and CSF was Gram 
stained and cultured in the hospital laboratory. 
Upon a negative result, latex agglutination tests were 
used to detect antigens of Hib, S. pneumoniae and N. 
meningitidis. Remaining CSF was stored in tubes and 
placed in a freezer (-70°C) before transportation for 
real-time PCR to Portugal or Finland. 
Basic laboratory samples were drawn upon ad-
mission and in the ward. Those used to characterise 
or compare patients in the studies II–IV consisted 
of the following: CSF leukocyte and glucose counts, 
blood haemoglobin, leukocytes, sedimentation rate, 
CRP, malaria thick film, HIV serology and Mantoux 
positivity. These analyses were performed locally fol-
lowing standard laboratory procedures.
4.3.2.3  Neurological evaluation
Neurology was examined upon admission, on the 
ward, at discharge and during scheduled follow-up 
visits by study physicians. 
4.3.2.4  Auditory brainstem response  
 protocol 
A 1-channel ABR recording (Bera MADSEN Octa-
vus® system v.2.001, Windows XP/2000 compatible; 
GN Otometrics, Taastrup, Denmark) was performed 
on patients within 24 h of admission, again on day 7, 
and during scheduled follow-up visits. 
Before initiating the trial, study nurses received 
detailed training on how to perform the ABR re-
cording. No medical sedation was used, but ABR 
was performed bedside during coma or natural 
sleep (Figure 8) or in a comfortable position, with 
child lying in his or her parent’s lap. If children were 
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conscious prior to the recording, they were encour-
aged to close their eyes, while young children were 
soothed by breastfeeding them, thus allowing them 
to calm down and fall asleep. 
Figure 8. Recording an auditory 
brainstem response from an un-
conscious child being treated for 
childhood bacterial meningitis.  
Photo: Tuula Pelkonen.
After cleaning the skin, electrodes were posi-
tioned on the mastoids and high forehead. Broad-
band click stimuli were delivered to the ear exam-
ined using headphones and intensities of 80, 60 and 
40 dB, while the contralateral side received masking 
with a 20-dB lower stimuli. The potential difference 
between the mastoid of stimulated ear and vertex 
was recorded (Figure 9). 
In all ABR evaluations, evaluators were blinded 
to the individual outcome of each patient. Expert 
ENT physician from the Audiology Centre of Hel-
sinki interpreted the ABRs in Finland in terms of the 
ABR thresholds (study III). The authors of study IV 
further categorised the responses using visual analy-
sis after training for ABR evaluation (study IV). We 
used a simple and pragmatic categorisation based 
on robust changes applicable in clinical settings—
that is, those with a bilateral absence and those with 
wave forms present from at least either side. Expert 
audiologist and neurophysiologists were consulted if 
Figure 9. Recording a 1-channel 
auditory brainstem response. 
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necessary. The peak latencies of waves I, III, and V 
were measured when they were identifiable from the 
traces of 80-dB clicks and IPLs I to III (I–III), III to 
V (III–V) and I to V (I–V) were calculated. In the 
case of asymmetries in latencies and estimated hear-
ing levels, the better ear (lower estimated threshold, 
fewer delayed latencies) was chosen for analysis. 
4.4 Description of variables and outcome measures (studies II–IV)
Voluntary children (n = 101), most outpatients 
of the hospital and some accompanying family 
members participated as controls undergoing ABR 
recording. Those with abnormal findings in pneu-
matic otoscopy, history of HI or BM were excluded. 
ABR was successfully recorded for 64 children, for 
whom latency and IPL parameters were obtained. 
The variables used to describe the BM patients in 
each study consisted of measures of demographic 
characteristics, antibiotic use prior to admission, 
symptoms and signs of acute illness before and 
during admission, on the ward, at discharge, and 
during follow-up visits as well as clinical parameters 
and additional treatments and diagnosis.
A lack of home telephone indicated a low so-
cioeconomic position of the families. Those chil-
dren who upon admission had a weight-for-age <–2 
SDs of the WHO reference values and additionally 
showed severe dyspnea, were defined as presenting 
in a poor general condition. The Glascow Coma 
Scale (GCS) served to quantify consciousness—that 
is, scores below 15 were considered altered and a 
score of less than 7 was defined as a coma. Seizures 
and focal neurological signs were also recorded. Fur-
thermore, additional infectious focus, other than 
BM and OM such as pneumonia were diagnosed 
during a hospital stay. Second-line antimicrobials 
and treatment for malaria and tuberculosis were also 
noted. In ABR, the absence of a response was defined 
as no replicable V wave in superimposed tracings at 
an 80-dB stimulus level bilaterally. The delay of la-
tencies and IPLs of ABR were defined as a deviation 
of > +2 standard deviations (SDs) of age-appropriate 
control at an 80-dB stimulus level.176,181 
The primary outcome measures used in the men-
ingitis studies (studies II–IV) consisted of the fol-
lowing: death and death combined with complicated 
clinical course (study II); hearing impairment in the 
better hearing ear or either ear amongst survivors, and 
a hearing impairment of all ears pooled together, prior 
to the discharge (study III); death and death combined 
to severe neurological sequelae, referred in the text 
also as a poor outcome (study IV). Table 6 summarises 
the main variables and outcome measures. 
Death rates were based on mortality during a hospi-
tal stay after inclusion in the study and before hospi-
tal discharge.
A complicated clinical course was defined as having 
focal convulsions or focal neurological symptoms, 
prolonged convulsions after the third day of the treat-
ment or an additional infection other than OM. 
Severe neurological sequelae consisted of blind-
ness, tetraplegia, severe psychomotor retardation or 
hydrocephalus upon discharge. Any neurological se-
quelae also involved hemiparesis, monoparesis, any 
psychomotor retardation or ataxia. 
Hearing impairment was defined as an elevated ABR 
threshold (>40 dB) in the better-hearing ear or either 
ear in children, or in a group of all ears. The estimat-
ed hearing threshold of each ear was defined as the 
lowest stimulus level producing a detectable ABR (V 
wave). We differentiated between four ABR thresh-
olds: 40 dB, 60 dB, 80 dB and >80 dB. Thus, the esti-
mated hearing thresholds indicated normal hearing, 
a moderate-to-severe HI, and severe HI, respectively. 
An absent response at all three stimulus levels was 
considered as an ABR-threshold >80 dB, indicating 
profound HI or, more precisely, deafness.
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Table 6. Main characteristics of the studies of bacterial meningitis included in the thesis.
Study II Study III Study IV
Study patients Patients with ear status de-
termined upon admission
Survivors with ABRa 
before discharge
Patients with ABR from ad-












Age (cut-off at 12 months)
Absence or presence of 
latencies






Death or complicated 
clinical course
Hearing impairment in 
better ear
Hearing impairment in 
either ear
Hearing impairment in all 
ears
Death
Death or severe neurologi-
cal sequelae
aABR, auditory brainstem response
bGCS, Glascow Coma Scale
4.5 Statistical analyses
Dichotomous categorical variables were compared 
using chi-squared test or when not applicable, the 
Fisher’s exact test. With continuous variables, nor-
mality of the data was tested with visual inspection. 
Non-parametric tests were used in case of skewness. 
We used nonparametric Mann–Whitney U test to 
compare medians, and the parametric Student’s t-test 
to test means. When comparing differences across 
several groups, contingency tables larger than two-
by-two were applied for dichotomous categorical 
variables and the nonparametric Kruskall–Wallis test 
for continuous variables. In addition, univariate lo-
gistic regression analysis was used to study the asso-
ciation between variables. For a multiple logistic re-
gression analysis, selected variables with a sufficient 
number of patients and p < 0.1 were selected. Confi-
dence intervals (CIs) of 95% were calculated for odds 
ratios (OR). We considered p < 0.05 as statistically 
significant. Statistical analyses were performed using 
StatView version 5 for Windows and IBM SPSS sta-
tistics 22.0 and 23.0 for MacOS. In addition, we used 
NCSS 12 (NCSS, LLC, Kaysville, UT, USA). 
4.6 Ethical considerations
During our January 2017 research visit, we con-
firmed the institutional ethical approval for study I. 
The ethics committee approved the original BM 
study (ISRCTN62824827) after rejecting the use 
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of corticosteroids as an adjunctive therapy.112 An 
amendment covering subsequent studies (studies 
II–IV) was approved on 21 December 2007. Data 
collection began after a child’s parent or guard-
ian provided their informed consent. An external 
monitoring board oversaw the prospective trial, 
whereby all data were sent to the board during the 
ongoing trial. If the outcomes amongst children 
had differed significantly, the study would have 
ceased. 
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5. Results
5.1 Characteristics of study patients (studies I–IV)
Table 7 summarises the main characteristics of pa-
tients included in the studies I–IV. Study III consists 
of survivors from BM. The subsets of BM patiens in 
studies II–IV are presented in Table 8.
Table 7. Main characteristics of children included in the studies I–IV
Study I Study II Study III Study IV







Patients, n 654 512 351 221
Age in months, median (IQR) n/a 13 (33) 13 (34) 20 (42)
Female, % 44 45 48 41
Number of children living in  
the household, median (IQR)
n/a 3 (2) 3 (2) 3 (2)
No telephone at home, % n/a 42 43 45
 
N/a, not available.
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Table 8. Underlining comorbidities, history of acute illness, and clinical and labo-









Malnutritiona, % 32 27 33
HIV test positive, n/n (%) 34/427 (8) 21/319 (7) 8/185 (4)
SCD screening test positive, n/n (%) 117/345 (34) 82/271 (30) 51/164 (31)
Malaria parasites, n/n (%) 160/498 (32) 103/341 (30) 68/214 (32)
Mantoux test >10 mm, n/n (%) 41/338 (12) 41/287 (14) 22/150 (15)
History of acute illness
Duration of symptoms before admission in days, 
median (IQR)
4 (5) 4 (4) 5 (4)
Duration of symptoms > 7 days, % 22 19 24
Convulsions prior to admission, % 68 62 67
Antibiotic use prior to admission, % 41 39 35
Findings on admission
Poor general condition, % 46 42 44
Altered consciousness, % 64 54 63
Coma, % 18 15 19
Focal neurological signs, % 20 21 18
Dehydration, % 16 13 15
Dyspnoea, % 43 40 45
Laboratory
Blood leukocytes, median /µL (IQR) 15 (12) 14 (11) 14 (10)
CRP, median mg/L (IQR) 149 (94) 153 (110) 31 (104)
Blood haemoglobin, mean mg/L (SD) 7.6 (2) 7.7 (2) 7.8 (3)
CSF leukocytes, median x106/L (IQR) 645 (1830) 790 (2840) 1033 (2280)
CSF glucose, median mg/dL (IQR) 14 (26) 14 (29) 19 (34)
Causative agent identified in CSF, n (%) 
     Hib  
     S. pneumoniae  
     N. meningitidis  
     Other bacteria 
     No causative agent identified in  



















CRP, C-reactive protein; CSF, cerebrospinal fluid; SCD, sickle-cell disease.
aDiagnosed as weight-for-age <–2 SDs of the WHO reference values.
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5.2 Discharging ear infections in children in Luanda and Africa (study I)
 
5.2.1   The microbiology of otorrhoea in Luanda
A sample was taken from 678 draining ears. In to-
tal, bacteria were isolated from 542 (80%) ears rep-
resenting 32 different bacteria (Figure 10). The ma-
jority of isolates consisted of Gram-negative bacteria 
(n = 459, 85%), more specifically enteric rods (n = 
284, 52%). Pseudomonas spp. was the most frequent 
isolate (n = 158, 29%) followed by Proteus spp. (n = 
134, 25%) and Klebsiella spp. (n = 36, 7%). S. aureus 
emerged as the most common Gram-positive agent 
(n = 54, 10%) followed by S. pneumoniae (n = 21, 
4%). Several pathogens, including Salmonella spp. 
(14 children, 3% of isolates), Shigella (7 children, 1% 
of isolates), Yersinia spp. (4 children, 1% of isolates) 
and zoonotic Edwardsiella tarda (3 children, 1% of 
isolates), were identified. The annual isolation rates 
of bacteria appear in Figure 11. 
Figure 10. Distribution of 542 
bacterial isolates cultivated from 
678 draining ears from children, 
Luanda, Angola, 2008–2015.













        Proteus spp.
        Klebsiella
        E. coli
        Citrobacter
        Pantoae agglomerans
        Salmonella
        Shigella
        Other 
        Enterobacteriaceae
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Figure 11. Annual isolation rates of bacteria from 678 otorrhoea samples from children 
from Luanda, Angola, shown as proportions. The numbers at the top of the columns 
represent all of the samples drawn. For positive cultivation rates, the 95% CI are shown. 
*Represents the contaminated growth detected on the cultivation plates, no results. 
Susceptibility analyses revealed a 93% quinolone 
sensitivity to the four most common isolates. How-
ever, resistance was noted for S. aureus; amongst the 
isolates tested, 69% (n = 18/26) were Methicillin-re-
sistant S. aureus (MRSA). Isolates producing extend-
ed-spectrum β-lactamase (ESBL) constituted 14% (n 
= 16/110) of all Enterobacteriaceae. 
5.2.2 A review of discharging ear 
infections in African children 
Our literature search yielded 160 citations, of which 
we included 20 in our review. From these, 12 publica-
tions provided data on the prevalence and the burden 
of otorrhoea or CSOM, while 8 publications includ-
ed microbiological data. Figure 12 shows the stud-
ies reporting prevalence and occurrence of CSOM 
and otorrhoea. These studies are listed in Table 2 of 
the original publication (study  I).15,28,55,69,76,78,79,184-186 
Table  9 presents the aetiological findings report-
ed.38,39,187-192 In addition, 2 publications evaluated 
the burden of OM, which accounted for 45% of all 
new paediatric ENT cases and 5% of all paediatric 
visits.193,194 Most studies consisted of hospital-based 
samples, whereas few population-based studies pro-
vided data amongst children. The review revealed a 
high prevalence for CSOM and otorrhoea amongst 
African children. Furthermore, an uneven distribu-
tion of the origin of studies was noted.
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Figure 12. Prevalence and occurrence of CSOM and otorrhoea  
among children ≤15 years of age in Africa, 1997–2017.  
The numbers in the map correspond to the references. 
*Prevalence classification by WHO1. 
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Table 9. Primary pathogens in ear pus samples taken from children ≤15 years of age 
diagnosed with otorrhoea and CSOM in Africa, 1997–2017. 
Reference Country N isolates Main pathogens, 




Ethiopia 256 Proteus spp. 47 
S. aureus 36 
Abera and Kibret,
2011187
Ethiopia 331 Proteus spp. 31 
S. aureus 23 
Pseudomonas spp. 19 
Bello et al.,
2011188
Nigeria 289a S. aureus 40 
Proteus spp. 28 
E. coli 11
Nnebe-agumadu et al., 
2011189
Nigeria 61 Pseudomonas spp. 57
Klebsiella 16
Proteus spp. 11 




Muleta et al., 2004191 Ethiopia 99 Proteus spp. 43
S. aureus 14 
P. aeruginosa 13
Tiedt et al., 201339 South
Africa
153 Proteus spp. 22 
P. aeruginosa 14
H. influenzae 14
Matundwelo and  
Mwansasu 2016192
Zambia 60 Staphylococcus spp. 37
Proteus spp. 35
Pseudomonas spp. 15
aAetiologies reported among those with antimicrobial susceptibility tested (289 of 301 isolates).
5.3 Otorrhoea and otitis media in  
 childhood bacterial meningitis (study II)
In total, 62 from 512 children (12.1%) had OM, diag-
nosed as either discharge originating from the middle 
ear (n = 39) or middle-ear effusion as well as the symp-
toms and signs of an infected middle ear (n = 23). 
Our analysis revealed that those with OM or 
otorrhoea were sicker upon arrival and more of-
ten exhibited a complicated or a fatal course of BM 
(Tables 10 & 11). In children with OM, multiple in-
fectious foci (32%) and dehydration (26%) upon 
admission were common. Furthermore, otorrhoea 
associated with being HIV-positive (19% vs. 7%, p 
= 0.026). OM patients were older compared to non-
OM patients, and those with otorrhoea were even 
older in comparison to non-OM patients (median 
age of 24 months and 45 months vs. 12 months, re-
spectively, p < 0.001).
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Table 10. Clinical and laboratory findings of children with bacterial meningitis and
otitis media (OM) or otorrhoea compared to those with normal middle-ear status








Malnutritionb, n (%) 23 (37) 15 (38) 142 (32)
HIV test positive, n/n (%) 6/50 (12) 6/32 (19)0.026 28/377 (7)
SCD screening test positive, n/n (%) 12/36 (33) 8/26 (31) 105/309 (34)
Malaria parasites, n (%) 20 (32) 14 (36) 141 (31)
Mantoux test positive (>10 mm), n/n (%) 8/41 (20) 6/27 (22) 33/297 (11)
Findings upon admission
Poor general condition, n (%) 35 (56) 23 (59) 198/449 (44)
Dehydration, n (%) 16 (26)0.040 8 (21) 66 (15)
Altered level of consciousness, n (%) 46 (74) 28 (72) 281 (62)
Focal neurological signs, n (%) 12 (19) 6 (15) 90 (20)
Ptosis, oculomotorius paresis, n (%) 2 (3) 2 (5)0.020 4 (1)
Additional focus of infection, n (%)  








Blood leukocytes, median /µL (IQR) 14 (12) 13 (9) 15 (12)
CRP, median mg/L (IQR) 144 (108) 130 (92) 149 (94)
Blood haemoglobin, median mg/L (IQR) 8 (4) 8 (4) 8 (2)
CSF leukocytes, median x106/L (IQR) 450 (1668) 400 (1500) 683 (1880)
CSF glucose, median mg/dL (IQR) 13.4 (28) 13.1 (18) 15.7 (26)
Causative agent identified in CSF, n (%)
      Hib  
      S. pneumoniae 
      N. meningitidis 
     Other bacteria
















Statistical significance (p < 0.05) in the superscript. Statistical tests performed included the Mann–Whitney 
U test, the chi-squared test and the Fischer’s exact test. CRP, C-reactive protein; CSF, cerebrospinal fluid; SCD, 
sickle-cell disease.
aOtorrhoea group is included in the OM group
bDiagnosed as weight-for-age <–2 SDs of the WHO reference values.
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Table 11. Clinical outcome of children with bacterial meningitis and otitis media 
(OM) or otorrhoea compared to those with normal middle-ear status (non-OM) in 
Luanda, Angola.
Outcome at discharge OM
n = 62 
Otorrhoeaa
n = 39 
Non-OM
n = 450
Death, n (%) 19 (31) 13 (33) 121 (27)
Fatal or complicated clinical course, n (%) 55 (89)0.046 34 (87) 349 (78)
Days hospitalized before death, 
median (IQR)
6 (7) 6 (7)0.029 4 (4)
Death or severe neurological sequelae, 
n (%)
27 (44) 17 (44) 164 (36)
Severe neurological sequelae, n/n (%) 9/43 (21) 4/26 (15) 43/329 (13)
Any neurological sequelae b, n/n (%) 23/43 (53) 14/26 (54) 168/329 (51)
Ataxia, n/n (%) 21/43 (49) 13/26 (50) 159/329 (48)
Statistical significance (p < 0.05) in the superscript. Statistical tests performed included 
the Mann–Whitney U test, the chi-squared test and the Fischer’s exact test.
aOtorrhoea group is included in the OM group
bOther than ataxia.
OM increased the likelihood of death or a com-
plicated clinical course to 2.27 (95% CI 1.004–5.15) 
in our univariate logistic regression analysis (Table 
12), remaining significant in the multivariate analy-
sis [odds ratio (OR) 3.44, 95% CI 1.29–9.16]. Other 
significant risk factors in our multivariate analy-
ses consisted of an age under 12 months (OR 2.07, 
95% CI 1.17–3.67), malnutrition (OR 2.26, 95% CI 
1.22–4.19), pre-admission convulsions (OR 2.40, 
95% CI 1.41–4.07) and an altered state of conscious-
ness upon admission (OR 1.97, 95% CI 1.17–3.34). 
N. meningitidis associated with fewer fatalities or a 
less complicated clinical course (OR 0.31, 95% CI 
0.13–0.74).
We conducted further analyses in infants (≤12 
months, n = 249) and in those older than 12 months 
(n = 263). Infants presenting with concomitant 
otorrhoea (n = 8) more frequently lived in families 
without telephones (88% vs. 48%), had no previ-
ous antimicrobials administered (0% vs. 48%), were 
malnourished (50% vs. 17%), showed lower medi-
an blood leukocyte counts (median 4/µL vs. 15/µL) 
compared to infants with non-OM (n = 229). The 
OM-infants (n = 20) died later (median day 6 vs. day 
3) than non-OM infants.
Amongst children older than 12 months, those 
with otorrhoea (n = 31) were admitted to hospital lat-
er (after 7 days in 33% vs. 16%), required second-line 
antibiotics (39% vs. 19%) and malaria treatment 
(84% vs. 66%) more often whilst hospitalised com-
pared to non-OM children (n = 221). Their hospital 
stays were longer (median 15 days vs. 9 days) and the 
clinical course was more often fatal or complicated 
(87% vs. 70%) compared to those without OM. 
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Table 12. Risk factors for death or a complicated clinical course in univariate  
logistic regression analysis.





Age under 12 months 2.23 (1.43–3.48) <0.001
No telephone at home 1.62 (1.04–2.54) 0.033
Comorbidities
Malnutritiona 1.76 (1.08–2.88) 0.02
HIV test positiveb 1.80 (0.67–4.78) ns
SCD screening test positivec 1.37 (0.79–2.39) ns
History of acute illness
Duration of symptoms >7 daysd 2.73 (1.44–5.18) 0.002
Convulsions prior to admission 3.70 (2.38–5.75) <0.001
Antibiotic use prior to admission 1.88 (1.18–3.02) 0.009
Findings on admission
Altered level of consciousness 2.68 (1.73–4.15) <0.001
Dehydration 2.80 (1.31–6.01) 0.008
Dyspnoea 2.91 (1.80–4.72) <0.001
Otitis media 2.27 (1.004–5.15) 0.049
Otorrhoea 1.97 (0.75–5.16) ns
















OR, odds ratio in univariate logistig regression analysis; CI, confidence
interval; Ns, not significant; CSF, cerebrospinal fluid; SCD, sickle-cell disease.
aDiagnosed as weight-for-age <–2 SDs of the WHO reference values.
bn = 427, cn = 345, dn = 509.
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Prior to hospital discharge, a hearing examination 
was successfully completed on 351 of 451 (78%) sur-
vivors and 685 of 902 (76%) ears. A bacterial aeti-
ology was identified in 224 (64%) of these children, 
consisting of 99 Hib cases (28%), 82 S. pneumoniae 
cases (23%), 31 N. meningitidis cases (9%) and 12 
other bacteria (3%). In 51 (11%) children, BM was 
confirmed based on our diagnostic criteria, whilst 76 
(17%) children remained classified as suspected BM. 
Severe or profound HI was common amongst 
survivors [65 of 351 (19%)], given that 45 (12.8%) 
Figure 13. Percentages for the better-hearing ear’s estimated threshold from 351 
survivors of bacterial meningitis (BM) from auditory brainstem response recordings 
prior to hospital discharge in Luanda, Angola. The absolute numbers of children are 
shown at the end of each bar.  
*Proteus mirabilis (3), Salmonella spp. (3), other streptococcal species (2), Staphylo-
coccus aureus (2), Klebsiella (1) and unidentified bacteria (1). 
**Symptoms and signs of BM with a positive blood culture, leukocyte concentra-
tions in cerebrospinl fluid exceeding 100 x106/L, a C-reactive protein concentration 
higher than 381 mmol/L (40 mg/L) or a positive Gram-stain. 
5.4 Hearing impairment in childhood bacterial meningitis (study III)
became deaf (ABR threshold >80 dB) and 20 (6%) 
exhibited an ABR threshold of 80 dB in the bet-
ter-hearing ear. Furthermore, 30 children (9%) ex-
hibited an ABR threshold of 60 dB. The plots of the 
ABR thresholds in the better-hearing ear appear in 
Figure 13. No clear association between HI and any 
of the aetiological groups emerged. HI of any degree 
(ABR threshold >40 dB) in reached 34% with Hib, 
30% with S. pneumoniae, 19% with N. meningitidis 
and 33% with other bacteria.
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When any degree of HI (ABR threshold >40 
dB) in either ear in children was analysed, N. men-
ingitidis caused less (28% vs. 55%, p = 0.006) and 
Hib more (59% vs. 45%, p = 0.038) HI compared 
to other identified aetiologies. When looking at the 
ears only, we found a significant difference. With a 
known bacterial aetiology, meningococcal meningi-
tis caused significantly less HI of any degree in com-
parison to other causative organisms (22% vs. 45%, 
p = 0.001) (Figure 14). 
Figure 14. Percentage of hearing impaired and unimpaired ears with known 
 bacterial aetiology (n = 383) in children surviving bacterial meningitis from auditory 
brainstem response recordings prior to hospital discharge, Luanda, Angola. 
The majority of survivors, consisting of those 
tested for hearing and with a confirmed bacterial ae-
tiology, were under 12 months of age. HI in the bet-
ter-hearing ear was detected more often in children 
under 12 months compared to older children at the 
cut-offs of >40 dB and >60 dB [38% (n = 46 of 120) 
vs. 22% (n = 23 of 104), p = 0.0087 and 27% (32 of 
120) vs. 14% (n = 15 of 104), p = 0.025, respective-
ly]. If the bacterial aetiology was known, more HI in 
either ear (>40 dB) was detected in infants less than 
12 months of age than in older ones [63% (n = 74 of 
117) vs. 38% (n = 39 of 103), p = 0.0002].
In children under 12 months of age, S. pneumo-
niae was harmful and caused deafness more often 
than other identified organisms (31% vs. 12%, p 
= 0.025) as well as a HI at the ABR threshold >60 
dB (41% vs. 21%, p = 0.017). In children at least 12 
months old, Hib caused more HI at an ABR thresh-
old >60 dB than other causative organisms (26% vs. 
10%, p = 0.031). 
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5.5 Prognostic value and changes to the auditory  
 brainstem response (study IV)
Overall, 55 of 221 (25%) children died, whilst 22 of 
221 (10%) experienced severe neurological sequelae 
at discharge. The absence of a typical ABR waveform 
on the first-day recording bilaterally was common 
(48%) and was not associated with mortality or 
mortality combined with severe neurological inju-
ry upon hospital discharge (p > 0.05 for both cross 
tabulations, Table 13). Furthermore, no association 
emerged comparing those with an altered conscious-
ness or comatose patients (p > 0.05 for both cross 
tabulations). Repeating ABR on day 7 (n = 166) 
added no value, since the outcome did not differ 
between those whose response was present versus 
those for whom a response was absent in the repeat-
ed measurement in relation to death (5% vs. 11%, p 
> 0.05), in relation to death combined with a severe 
neurological injury (17% vs. 23%, p > 0.05) or in an 
univariate logistic regression analysis (p > 0.05).
The latencies and IPLs measured in the bet-
ter-hearing ear of the remaining children (n = 114) 
emerged as longer in those patients who died or de-
veloped severe neurological injury, although these 
differencies were not statistically significant (p > 0.05 
in all comparisons based on age groups). In further 
analyses, we examined the association between de-
layed ABR parameters on poor outcome. We found 
no statistically significant differences in the delay 
between those who died or survived, both amongst 
all patients or amongst those with an altered con-
sciousness (p > 0.05 for all cross tabulations). How-
ever, a delay occurred more commonly in children 
who died or who developed neurological sequelae 
in comparison to those who survived: amongst all 
patients (43% vs. 22%, p = 0.024) and amongst those 
with an altered consciousness (44% vs. 22%, p = 
0.043). 
Table 13. ABR characterisation versus outcomes in cross tabulations
ABR characterisation Death or severe  
neurological sequelae




All 35/76 (46) 72/145 (50) ns
Altered consciousness 33/68 (49) 35/72 (49) ns
Coma 12/21 (62) 12/20 (60) ns
Delay of absolute or interpeak latenciesa
All 17/40 (43) 16/72 (22) 0.024
Altered consciousness 15/34 (44) 8/37 (22) 0.043
Coma n/a n/a -
Data are numbers and proportions (%) used in cross-tabulations.
Ns, not significant; N/a, not applicable due to insufficient number of patients.
aA delay of latencies of waves III, V or interpeak latencies of I–III, III–V or I–V. 
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Additionally, we observed a significant differ-
ence between BM patients and the control chil-
dren. These differences consisted of the following: 
amongst infants and young children (<24 months) in 
the latency of wave V (p = 0.001) and IPLs of III–V 
(p = 0.005) and I–V (p = 0.003) and amongst chil-
dren older than 24 months for wave I (p = 0.041), III 
(p = 0.003) and V (p = 0.001) and IPLs for I–III (p = 
0.04) and I–V (p = 0.019). These latencies were de-
layed in patients (Figure 15 for selected parameters). 
Figure 15. The latency of wave V and interpeak latencies I–V in the auditory brain-
stem responses at an 80-dB stimulation level in patients with bacterial meningitis 
(n = 114) and controls (n = 64) from Luanda, Angola.  Children <24 months of age 
are shown on the left side while children ≥24 months of age are plotted on the right 
side. The nonparametric Mann–Whitney U test was used for all comparisons.
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 6. Discussion
 
6.1 Otorrhoea and neglected middle-ear infections 
 
Study I sought to analyse the findings from otor-
rhoea samples: the bacterial aetiology, their change 
over time and their antimicrobial patterns. Our 
findings show that the predominant bacterial iso-
lates in ear discharge were numerous and versatile, 
also containing bacteria atypical for ear discharge 
found amongst children in high-income settings.12 
The data support our hypothesis that otorrhoea in 
children in low-income settings show specific char-
acteristics. The observational study design and a lack 
of more specific data do not allow us to draw more 
precise conclusions, however. In addition, some of 
the isolates may represent normal flora. Therefore, 
the bacteria that maintain infections in the middle 
ear in chronic otorrhoea remain uncharacterised.26 
The high prevalence of Gram-negative rods 
(84%) parallels other studies from lesser developed 
parts of the world.35 Moreover, results finding Pseudo-
monas spp. in 29% and Proteus in 25% of cases agree 
with the findings from other laboratory-based series 
from Africa, which reported prevalences of 19% to 
57% for Pseudomonas spp.187,190 and 11% to 47% for 
Proteus,38,189 respectively. The detection rate of 10% 
for S. aureus is close to the rate of 12% found in a 
prospective study of CSOM from Kenya, although 
that study extended to adulthood.37 The prevalence 
of S. aureus in Africa remains high in all-cause otor-
rhoea, and was the most common isolate in a recent 
report from Ethiopia. 81 Some studies, however, de-
tected notably more Proteus – an organism that was 
the most common isolate in Kenya (32%)37 and in 
Ethiopia (31–47%)38,187 in children.
The true meaning of finding unexpected patho-
genic bacteria such as Shigella and Salmonella de-
tected in our sample remains elusive, since we do 
not yet know if they represented the actual causes of 
otorrhoea. Nor could we trace whether these patho-
gens associated with severe immunodeficiencies. A 
previous study from the same laboratory identified 
Shigella in an otorrhoea sample.56 However, the de-
tection of unexpected bacteria frequently occurs in 
Africa, where traditional treatment practices using 
animal and plant extracts administered directly into 
the ear remain common even amongst children.16 
Briefly, Alcaligenes faecaelis, which is typically found 
in pigeon faeces, an ingredient used in traditional 
ear medicine, was isolated in CSOM in Angola, and 
otogenic tetanus is not rare in  Africa.37,195
Whilst speculative, it is possible if not likely that 
these findings are affected by poverty. For instance, 
lack of clean water, close contact to soil, human and 
animal faeces, prevailing malnutrition and immuno-
suppression due to various reasons all relate to pov-
erty. Several studies have confirmed the association 
between poverty and chronic otorrhoea.27,31 
Our findings on antimicrobial susceptibility 
favour the current WHO recommendations for 
treating CSOM and persistent otorrhoea43 in An-
golan children since the sensibility to quinolones 
reached 93% for the four most common isolates. 
This finding agrees with observations from South 
Africa, where 95% of Gram-negative and 93% of 
Gram-positive bacteria in ear discharge showed 
susceptibility to quinolones.34,39 Similarly, in Zam-
bia and Nigeria, otorrhoea isolates were suscep-
tible to quinolones albeit at lower susceptibility 
rates.188,189,192 A recent study from Angola amongst 
children and adults diagnosed with CSOM found 
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susceptibility to ciprofloxacin in 92% of Pseudomo-
nas and 85% of Proteus cases.196
Knowledge regarding current susceptibility 
trends is particularly valuable for situations when 
cultivation is not readily available. The high preva-
lence of MRSA raises concerns and should caution 
clinicians when choosing antimicrobials beyond 
ear-related conditions. The ESBL strain prevalence 
of 14% in Enterobacteriachae is consistent albeit low-
er than a reported prevalence of 23% from Africa.197 
Taking into account the variety of bacteria and the 
possibility of resistance, our data support sampling 
and cultivation whenever resources permit.
Our literature review aimed to systematise 
knowledge on prevalence, occurrence and burden of 
disease and allow comparison across microbiolog-
ical findings amongst African children. Our litera-
ture search revealed possible gaps in knowledge on 
paediatric otorrhoea and CSOM during the past two 
decades. Population-based studies reporting on chil-
dren remained scarce, whilst even less was identified 
for children U-5. Notably, few studies exist on OM 
burden from emergency and paediatric units. Our 
literature review, however, showed high prevalence 
for CSOM, similar or occasionally higher than those 
presented in 2004 by WHO.1 
The high number of children with otorrhoea 
reported in African studies suggests that AOM is 
not well recognised in Africa. Most children are 
brought in late when the TM(s) have already per-
forated.80 Care is primarily sought solely due to 
accompanying symptoms such as fever.80 Further-
more, access to care appears limited. For instance, a 
multiple indicator and health survey covering more 
than 16 000 households in Angola found out that 
only half of U-5 children with symtoms of potential 
pneumonia were taken to a health facility or health 
provider – an indicator from UNICEF indicating 
failure in seeking treatment and accessing care.198,199 
In Rwanda, only one-third of parents to children 
U-5 with active otorrhoea sought care via prescrip-
tion medications, whilst another one-third relied 
on traditional medications and one-third sought 
no care at all.16 In South Africa, half of the patients 
had received no treatment at all for a draining ear 
during the previous three months.39 Late presenta-
tions are common, allowing complications to oc-
cur (Figure 16). These findings call for intensified 
counselling regarding potential complications and 
the importance of seeking treatment early as part of 
disease prevention.  
Figure 16. A teenage boy 
from the Children’s Hospital 
of Luanda, Angola, present-
ing with chronic otorrhoea, 
and a necrotic ear canal and 
surrounding tissue. Photo: 
Dr. Manuel Leite Cruzeiro. 
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6.2 Concomitant otitis media in bacterial meningitis
Our observation that 12.1% of BM associated with 
OM agrees with the findings of Molyneux et al., who 
reported a similar percentage (12.4%) amongst ear 
infections in paediatric BM.96 Our result, however, 
differs from reported series from high-income set-
tings: Dodge et al., for instance, found accompany-
ing OM in 35% of cases, whilst Pedersen et al. found 
a prevalence of 45%.118,136 
Our finding that OM associated with a compli-
cated clinical course or fatality disagrees with find-
ings from Østergaad et al., who demonstrated that 
the case-fatality rate was lowest amongst those cate-
gorised as having otogenic BM.117 The differences in 
the underlying type of OM and illnesses predispos-
ing the individual to chronic otorrhoea likely explain 
these differences. CSOM may damage the middle ear, 
mastoid mucosa and connective tissue, and facilitate 
bacteria entering directly into CSF or via haemoato-
genic spread. Acquired deshiscencies are established 
risk factors for BM.200 Furthermore, we found that 
OM predicted a complicated clinical course or mor-
tality. This is similar to a meningitis study by van 
de Beek et al., who found that the presence of OM 
increased the odds 1.8-fold of an unfavourable out-
come (1–4 on Glascow Outcome Scale.129
This study contributes to the existing body of ev-
idence on the association of otorrhoea and HIV.20,55-57 
Compared with the reported frequencies of 54% to 
62% of HIV in otorrhoea, HIV in our BM patients 
with otorrhoea was less prevalent at 19%. The differ-
ence was, however, significant compared to BM pa-
tients without OM comorbidity, and even more than 
children from the general population in Angola. 
These findings outline the importance of HIV-test-
ing amongst patients with otorrhoea in Africa. HIV 
may represent a significant underlying factor leading 
to a more complicated clinical course or fatal out-
come in our study patients with OM; however, due 
to insufficient number of HIV-test results available 
we did not include it as a variable in our multivariate 
logistic regression analyses. 
Furthermore, discharging ears often associate with 
poverty, a likely underlying factor that may affect dis-
ease outcomes in multiple ways. Despite our attempts, 
we could not control for all possible confounders. 
Practically speaking, otorrhoea in Africa may be an 
indicator of underlying illnesses, and when associated 
with BM, may be indicative of a more complex clin-
ical course. Longer antibiotic treatment is likely nec-
essary with concomitant OM. In other words, typical 
short-course (5 days) antimicrobial treatments for BM 
in Africa are inadequate. In addition, atypical caus-
ative organisms of BM should be considered in cases 
of CSOM. Some of our cases may represent BM with 
an otogenic origin, which often manifests as multiple 
ICCs. Therefore, careful evaluation is warranted and 
an ENT intervention may be required.
The finding that N. meningitidis less often asso-
ciated with adverse outcomes is similar to a previous 
study in which McCormick et al. found a similar as-
sociation between N. meningitdis and fewer deaths 
amongst children with BM.114
6.3 Bacterial aetiology, age and hearing impairment  
 in bacterial meningitis
Study III of this thesis investigated how different 
bacterial aetiologies and age associated with audito-
ry outcomes. We paid particular interest to bacterial 
aetiology. The overall rate of deafness at 12.8% agrees 
with findings from Malawi and Kenya, where preva-
lences of 12% to 17% for severe to profound HI have 
been reported.84,115 
Our results mostly confirmed and agreed with 
a meta-analysis from 1993 and a later analysis of 
pooled data from Africa.132,201 These studies found 
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similar aetiology-related auditory outcomes associat-
ed with N. meningitidis, which posed the least potent 
to inducing any HI.132,201 Similar to our finding, Pelto-
la et al. found that N. meningitidis causes less HI.202 
In our sample when including all ears in the 
analysis, however, Hib associated more frequently 
with HI when compared to other agents (59% vs. 
45%, p = 0.038). These findings agree with a review 
of BM sequelae from Africa, in which the highest 
risk of HI associated with Hib.92 Similarly, a study 
from Latin America found that Hib aetiology as-
sociated with all of the elevated ABR thresholds 
studied.202 In our sample, Hib represented the most 
common isolated bacteria and may explain some of 
our results.
In two meta-analyses, S. pneumonia associated 
with the highest risk for HI.132,201 In our series, the 
detrimental effect of S. pneumoniae was evident 
amongst the youngest children, amongst whom we 
observed an association with deafness. Young age 
was, however, independently associated with HI. 
This agrees with previous findings.156,202 Because 
many of earlier studies vary with regards to the di-
agnosis of BM, testing methods, thresholds used and 
timing of testing, comparisons remain difficult. 
The potential of S. pneumoniae to damage hear-
ing is well-documented in animal models.105-107 As 
such, S. pneumonia may induce more inflammation 
and its toxins —such as pneumolysin — possess di-
rect ototoxic properties.141 In humans, the serotypes 
appear to play a role: 12F is more frequently and 6B 
less frequently associates with HI.203 Furthermore, 
S. pneumoniae leads to a higher rate of cochlear 
implantation and produces moderate and severe 
ossification of the cochlea more than other bacteri-
al agents.204 Moreover, compared to other agents, S. 
pneumoniae more often induces coma114 a risk factor 
for HI identified in previous studies.115,155,156
In resource-poor settings, the body of evidence 
points towards the severity of illness — that is, a deep 
or prolonged impaired consciousness — typically 
overriding the effect of other factors, such as disease 
aetiology. However, the effect of the aetiology may 
play a more important role in future if children with 
BM are admitted earlier and the severity of the dis-
ease is better controlled with advanced care. 
6.4 Auditory brainstem response in bacterial meningitis
Study IV evaluated whether the simple and robust 
categorisation of ABR upon admission and repeat-
edly in hospital carries any prognostic value and fea-
sibility in resource-poor settings. The role of more 
subtle changes in patient ABRs on different out-
comes and compared to healthy controls were also 
studied. Thus, the study questions were: Do changes 
in ABR associate with mortality or with mortality 
and severe neurological sequelae upon discharge?
This study showed that in our study setting ro-
bust changes to ABR carry no predictive value on 
survival compared to death, or on survival com-
pared to death or severe neurological injury on 
the first day of admission. This finding applied to 
all patients and subsequently amongst those with 
an altered consciousness or coma. Repeating the 
ABR later in hospital did not differentiate between 
patients, whereby adverse outcomes occurred re-
gardless of the pragmatic categorisation based on 
repeated recordings. These findings agree with a 
study of coma,170 wherein adverse outcomes oc-
curred even with normal, late ABR recordings. 
However, the results differ from a small series on 
tuberculous meningitis, in which an abnormal ABR 
correlating with death.176 
Since the elongation of IPLs following an in-
crease in ICP typically indicates an evolving brain 
death,170 we studied other ABR parameters in rela-
tion to poor outcomes. Furthermore, amongst our 
patients who developed poor outcomes, we noted 
a trend towards a longer latency and IPL time. This 
difference was, however, not statistically significant. 
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We identified those patients whose conduction time 
was most affected in comparison to age-matched 
controls. The low number of youngest children in 
the control group may have biased our results. The 
delay was more common amongst those with an un-
favourable outcome (43% vs. 22%). In other words, 
a poor outcome occurred in 52% of children with a 
marked delay compared with 29% without a delay, 
yielding a low specificity and sensitivity on disease 
prognosis. This differs from other studies of survival, 
where ABR showed high prognostic accuracy of an 
unfavourable outcome.171 
To better discuss the significance of our findings, 
the areas under the curve (AUCs) were also calculat-
ed for ABR delay and GCS from plotted receiver op-
erating characteristic curves (data not shown). AUC 
for delay remained low at 0.60 indicating a poor ac-
curacy and poor clinical applicability. GCS showed 
superior AUC values of 0.71, yet still providing only 
a fair accuracy for the prognosis.  
ABR does not provide direct information relat-
ed to the cerebral hemispheric function. The gross 
changes to ABR amongst our series with a bilater-
al absence of response may stem from a severe in-
crease in ICP, indicating imminent brain death or 
following ischaemia producing brainstem lesions 
involving the central auditory pathway. In our se-
ries, a significant proportion of children developed 
severe handicaps, which in other series has correlat-
ed with changes in the brainstem level.148 A high ICP 
and rostrocaudal deterioration of the brainstem and 
imminent brain death cause an absence of wave V, 
since wave V associates with brainstem compres-
sion.205 An increasing ICP alone may cause a reduc-
tion in the wave V amplitude.177,205 Since we found 
no correlation between an absent response and out-
comes, we assume that the cochlear-level patholo-
gies influenced our findings. 
BM-induced HI at the cochlear level may have 
influenced the delay of absolute latencies, although 
the ear with a lower ABR threshold was chosen for la-
tency and IPL analyses and a delay of latency I alone 
was not considered a genuine delay. Click stimuli ac-
tivates a high-frequency portion of the cochlea first, 
which dominates the generated synchronous neural 
activity.167 If BM damages the high-frequency por-
tion of the cochlea, the neural activity may have been 
generated more in the apical regions of the cochlea 
resulting in prolonged latencies.167 IPLs, by contrast, 
are generally thought to measure the CNS conduc-
tion time and reflect retrocochlear pathologies.167 
The observation that IPLs were largely affected on 
the first-day recording suggests that the infection 
process affects conduction at the brainstem level via 
other mechanisms.
Our findings regarding the delay of latencies or 
IPLs comparing patients and controls agree with 
previous studies on CNS infections.176,180,181 Those 
with a longer central conduction time suffered from 
significant changes to ICP and the cerebral perfusion 
pressure in previous studies,170,205 thus we may have 
indirectly measured elevated ICPs. In addition to 
ICP, vascular dysfunctions and ischaemia, demye-
lination represents another retrocochlear pathology 
possibly affecting ABRs.167 Finally, hydrocephalus, a 
complication associated with BM, can cause alter-
ations to ABR.176,181 All these mechanisms may have 
impacted our recordings. 
6.5 Strengths and limitations of the study
Observational studies are prone to certain lim-
itations and warrant a cautious interpretation of 
the results. Subgroup analyses carry the risk of 
false-positive findings.206 In this study, the ex-
tensive prospectively collected data in studies 
II–IV served as the basis for secondary analyses, 
to test hypotheses that were carefully thought-
out, clinically relevant and thus justified. We 
stated the hypotheses prior to conducting our 
analyses. 
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When applicable, we applied logistic regression 
analysis to strengthen the associations examined. 
The study samples across studies I–IV were relative-
ly large or larger in comparison to studies in similar 
settings. In addition, the outcome measures were 
carefully planned and likely hold an impressive va-
lidity. Generalisation of the results remains limited 
to similar settings, however, whereby our results ap-
ply best to children in similar socioeconomic condi-
tions and with comparable comorbidities. 
Furthermore, a selection bias may result in some 
limitations. In study I, for instance, only children 
referred to the Luanda laboratory for ear discharge 
sample collection were included in our study. In 
comparison to the prevalence estimates for the re-
gion, this represents only a fraction of all admis-
sions. The sampling activity diminished during the 
data collection. Clinical evaluation may have influ-
enced those cases for which a sample was obtained.   
In BM studies II–IV, we included subgroups 
based on our eligibility criteria. Thus, study II in-
cluded 71% of all patients based on otoscopic ex-
amination. Study III included 78% of all survivors 
based on an available ABR examination. A portion 
of the analyses, however, only included children or 
ears with a confirmed bacterial aetiology. Study IV 
included only 62% of those with ABR available based 
on an otoscopic examination. We argue that those 
children not fulfilling our inclusion criteria did not 
differ significantly from those included in the study. 
One exception, here, however, is death.  Because 
many of the children died during the first 24 hours, 
the case-fatality rate after the first ABR recording 
reamined lower than across the entire cohort albeit 
it still remained very high at 24%, thereby permitting 
analyses. 
Many of the limitations of the present study stem 
from the lack of resources characteristics of low-in-
come country settings. In study I, a lack of advanced 
patient data management systems prevented us from 
conducting more in-depth analyses.207 We could not 
definitively differentiate chronic otorrhoea from 
AOM with a perforation. In addition, in some cases 
otorrhoea may have developed from external otitis 
with an intact TM. Several pathogenic bacteria were 
isolated in otorrhea samples. Identification did not 
rely on PCR or other more sophisticated methods. 
In BM studies, latex agglutination and PCR were 
performed only for a minority of patients. The high 
number of cases with an unknown causative agent 
in CSF likely stems from the high use of preadmis-
sion antimicrobials in Angola. Recently in Finland, 
some of the frozen CSF samples without a known 
causative agent underwent PCR analysis. In 40 of 55 
(73%) samples, PCR revealed a causative bacterial 
agent. However, a portion of the children may have 
suffered from a different disease, including cerebral 
malaria, virus encephalitis, tuberculous meningitis 
and, in a few cases, trypanosoma infection. 
In relation to ear and auditory examinations, 
tympanometry, otomicroscopy and otoacoustic 
emissions would have supplemented the pneumatic 
otoscopy and ABR. Thus, we could not distinguish 
between conductive and sensorineural HI.208 The 
hearing threshold estimation may have been biased 
by other causes of HI including quinine treatment 
and ototoxic antimicrobials prior to hospital admis-
sion that we could not control. 
Audiology experts conducted the ABR-thresh-
old evaluation in study III. Findings from the 
pre-discharge hearing evaluations correlated with 
later hearing evaluations at follow-up.209 ABR may 
yield false-positive findings (no detectable latency 
for wave V at any stimulus level). In complete ab-
sence of latencies, deafness was always clinically val-
idated (the child did not respond to speech and claps 
amongst other stimuli).
The cut-off of HI was set to a fairly high lev-
el—40 dB, a level beyond the WHO-defined hearing 
threshold of a disabling HI in children.61 This serves 
as a strength of this study by eliminating some pos-
sible confounding due to conductive HI, but may 
underestimate the true degree of HI. A more precise 
examination of hearing requires frequency-specific 
evaluation permitting reliable categorisation based 
on WHO-defined hearing grades.61 Amongst in-
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fants, frequency-specific tone burst and auditory 
steady-state response would have provided addi-
tional information; amongst older children, pure-
tone audiometry would have yielded further details 
on hearing. Variations in ABR, such as chirp-stimuli 
that elicit improved synchronous activity of audito-
ry nerve fibres, produces better-defined amplitudes. 
Such methods could prove more practical when test-
ing hearing.210 Yet, a lack of resources and facilities 
prevented more comprehensive evaluations. 
We interpreted ABRs in study IV following de-
tailed training, and in cooperation with audiology 
and neurophysiology consultations. Blinding the 
clinical status of the patient may serve as a strength 
in our study; however, identification of wave V near 
the true threshold level can be challenging and ex-
amining only ABR tracing without validation from 
a clinical examination may cause some bias. Finally, 
at times, the signal-to-noise ratio may have over-
come averaging, resulting in a false-positive rating 
for the absence of wave forms. Performing CT scans 
and MRIs would have served to further examine the 
neurological sequelae and permitted a more detailed 
analysis of changes to the ABR central latency. 
The results from study IV should be interpreted 
with caution since cochlear-level HI may have affect-
ed the findings. To minimise the bias arising from 
HI, the side that showed the lowest ABR-threshold 
was chosen for our analyses and only the highest 
stimulus level was used. Within this study, we did 
not intend to control for other factors related to a 
patient’s dismal outcome and which have been pre-
viously intensely analysed; 157,211 instead our aim was 
to study specifically whether ABR would serve in 
prognostication of BM in settings where any tools 
for disease outcome are highly needed.
6.6 Future prospects
The Sustainable Development Goals (SDGs) includ-
ed in the 2030 Agenda for Sustainable Development 
aim to amongst other objectives ensure healthy lives 
and promote well-being for all, ensure inclusive and 
equitable quality education and promote lifelong 
learning opportunities for all. Under these goals, 
achieving universal health coverage and education 
for individuals with disabilities guide strategies to-
wards preventing OM, BM and their complications 
and managing disabling sequelae associated with 
these diseases.
6.6.1 Prevention of otitis media and 
bacterial meningitis in  
resource-poor settings
High vaccination coverage significantly prevents 
OM and BM episodes.99 Improved hygiene and 
sanitation could prevent some episodes of OM and 
BM. Improving health education amongst parents 
may result in earlier care-seeking behaviour allow-
ing early identification and more efficient OM and 
BM treatment. In African settings, almost one-quar-
ter of all children receiving a BM diagnosis initially 
sought care from traditional healers.152 At the com-
munity-level, healthcare workers may aid in raising 
awarness and promoting care seeking in relevant sit-
uations.212 Greater effort should be given to enabling 
access to health services.
6.6.2 Managing hearing impairment 
and neurological sequelae in 
resource-poor settings
As stated in the 2015 GBD study, the rising average 
YLD rates carry implications for health systems. 
With BM, the global YLDs have been increasing.22 
With a higher survival rate, more survivors will re-
quire specialised ear and hearing care (EHC), reha-
bilitation and education. Amongst survivors of BM, 
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the complex sequelae require a multi-disciplinary 
approach. This is particularly challenging in low- 
and middle-income countries, since their services 
already do not necessarily meet the population 
needs. 
An alarming shortage of ENT services and train-
ing opportunities persist in Africa.213,214 Whilst in 
Europe, one ENT specialist serves a population of 
20  000;215 by comparison, in Africa, one ENT sur-
geon and one audiologist typically exist per 1 million 
inhabitants.213 Subsequently, few advances have been 
reported.214 Some regions or countries continue to 
lack any of these services. In addition, families face 
several challenges accessing available services.216 In 
Angola, surgical treatment is limited; currently, the 
public ENT unit of Luanda only offers tympanoplasty 
(type 1). A lack of equipment prevents mastoidecto-
my at the moment. ENT surgery in the private sector 
is expanding; however, most patients suffering from 
CSOM can only afford treatment in the public sector.
 Similarly, rehabilitation services for cerebral 
palsy in Africa remain minimal.218 As such, commu-
nity-based rehabilitation programmes may carry a 
beneficial effect, although we continue to lack stud-
ies from children.219 Amongst cerebral palsy patients 
in Ghana, caregiver empowerment benefitted the 
affected families.220 Sustainable and accessible EHC 
services succeed when developed within an estab-
lished local healthcare delivery system.212 Outreach 
clinics may improve access to care and outcomes, 
particularly when integrated at the primary level al-
lowing for efficient on-site management.221 One pos-
sible means to reach remote communities may rely 
on advances in mobile diagnostics.76 For instance, 
a smartphone-based hearing screening technology 
proved equally efficient when compared to conven-
tional screening audiometry in terms of sensitivity 
and specificity, referral rate and time used in testing 
amongst school-aged children from underserved re-
gions in South Africa.222 
With SDGs in mind, WHO launched an initia-
tive aimed at preventing deafness and HI in 2017 
resolution, with calls to address EHC in several ways. 
The strategies outlined included, amongst others, 
integrating EHC strategies in primary health care; 
developing, implementing and monitoring screen-
ing programmes for the early identification of ear 
diseases such as CSOM in high-risk populations; 
improving access to affordable and cost-effective 
assistive hearing technologies; establishing training 
programmes in EHC; and promoting alternative 
communication methods.223 
6.6.3 Research prospects 
WHO’s 2017 resolution on the prevention of deaf-
ness and hearing also carries implications for the 
academy. High-quality population-based data on ear 
diseases remain needed, in addition to developing 
evidence-based strategies and policies. The possible 
gaps in knowledge of childhood OM and HI in Af-
rica are widely acknowledged.73 Recommendations 
for population-based studies on HI are available 
and should be taken into account when planning 
new epidemiological studies to enable comparisons 
between studies and populations as well as includ-
ed in GBD evaluations. Children U-5 should be 
included in such studies. In addition, prevention 
and intervention strategies specifically designed 
for resource-limited settings should be objectively 
planned and validated. 
With a deeper understanding of the interplay 
between different risk factors and pathological pro-
cesses, CSOM could be more efficiently prevented or 
treated in future. In BM, host–pathogen interactions, 
host–inflammatory reactions and brain and cochlear 
injury have all been intensely researched. In future, 
neuroregeneration may provide therapeutic inter-
ventions.106 Meanwhile, studies on adjuvant and op-
timized therapies, for instance with nonbacteriolytic 
antibiotics, are still needed, to enhance the outcome 
of this very detrimental disease of childhood.224 In 
resource-poor settings, protocols for optimised 
supportive therapies could also improve outcomes. 
The majority of children with BM in resource-poor 
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settings continue to receive treatment beyond inten-
sive-care facilities.
The broader spectrum of outcomes in BM, in-
cluding the quality of life, the effects on an individ-
ual’s psychosocial life and education, deserve further 
documentation. Data on cognitive delay, speech or 
language problems and behavioural issues are par-
ticularly lacking in low-income countries.92 Report-
ing of sequelae should follow uniform classifications. 
Strategies and standardised follow-up plans adjusted 
for low- and middle-income settings should be es-
tablished. In Senegal, for instance, no BM survivors 
received any follow-up care for 12 months following 
hospital discharge.111 
6.6.4 Ethical prospects
To improve the health and development status of 
LMICs, research on the causes of the greatest dis-
ease burden remains necessary and justified. The 
present study addressed problems highly prevalent 
in Angola. Although ethical standards of research 
are universal, and in our study were locally evalu-
ated, complexities of research of this kind specific 
to resource-poor settings may arise. For instance, 
in the absence of appropriate rehabilitation ser-
vices, researchers must ask to what extent is diag-
nostic testing ethically appropriate. However, gaps 
in knowledge can be considered obstacles to global 
health improvements. Understanding the burden 
of diseases, both at the individual and population 
levels, remains crucial when attempting to develop 
interventions and improve health systems capable of 
responding to population needs.
Sustainable solutions call for equal partner-
ships in and investments on local research in order 
for LMICs to become true producers and users of 
research. Local research may more likely stem from 
locally defined problems, produce culturally appro-
priate interventions and provide evidence-based 
strategies to tackle barriers preventing access to care 
in the population in question. Because systems pro-
viding research capacities often remain scarce, coor-
dinated interventions and strategies to build them 
are necessary.225
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7. Conclusions  
Based on the studies I–IV, we may draw the following conclusions: 
I A versatile range of bacterial species, in most cases Gram-negative rods (Pseudomonas spp.,  
Proteus spp. and Klebsiella spp.), cause otorrhoea in Angola. S. aureus remains the most common 
Gram-positive agent with a 69% representation of MRSA. Major aetiological shifts did not occur 
during the study period. Susceptibility to fluoroquinolone remains high.
Data on otorrhoea and CSOM amongst children in Africa is limited. The common bacterial 
agents in our study are similar to those from other African studies. The prevalence of persistent 
otorrhoea across studies appears sufficiently high to reach the magnitude of a public health concern. 
II Concomitant OM in BM is relatively common (12%) in Angola, displaying a complex presentation 
and clinical course. These children exhibit a higher risk of complicated disease or death. Those 
with otorrhoea likely originate from poor conditions, often have underlying illnesses and should 
be tested for HIV.
III Hearing impairment occurs frequently amongst BM survivors in Angola with a differing associati-
on between the bacterial aetiologies and the extent of hearing impairment. Age remains an impor-
tant factor contributing to the auditory outcome. Furthermore, S. pneumoniae seems particularly 
damaging to young children, whilst N. meningitidis associates with milder hearing impairment. 
IV A single or repeated ABR did not predict poor outcomes in Angola. Delayed latencies of waves 
III or V or IPLs associated with a higher rate of mortality or severe neurological sequelae, but 
were not relevant as a practical prognostic tool. Childhood BM affects the neural conduction 
time in the auditory pathway in the brain stem.
Based on this thesis, in future population-based stud-
ies on OM amongst African children including chil-
dren U-5 are warranted. Longitudinal cohort studies 
of BM from low-income countries would serve to 
clarify the interplay amongst various risk factors, the 
course and prognosis of disease and the true long-
term effects of BM. Furthermore, we need reliable 
and useful diagnostic tools for HI in resource-poor 
settings in order to plan and adjust rehabilitation 
services. Moreover, clinically relevant tools for prog-
nostics are still needed in resource-poor settings. 
Based on a broader perspective, future actions 
should focus on preventive strategies for OM and 
BM, including amongst others optimal childhood 
immunisations, improvements in hygiene, sanitation 
and living conditions and parental education; devel-
oping public health strategies to reach populations at 
the community level and allow for early identificati-
ton of diseases; improving access to care, hearing aids 
and hearing technologies; and supporting the reha-
bilitation and education of disabled children. 
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Conclusões  
Baseado nos estudos I a IV, podemos traçar as seguintes conclusões: 
I. Uma gama versátil de espécies de bacterias, na maioria das vezes  Gram-negativas (Pseudomonas 
spp., Proteus spp., Klebsiella spp.), ocasiona otorréia em Angola. S. aureus permanece como o agente 
Gram-positivo mais comum, com 69% de representação da S. aureus resitente à meticilina (SARM). 
Não houve maiores mudanças etiológicas durante este período de pesquisa. A susceptibilidade a 
fluoroquinolonas permanecere alta.
Os dados sobre a otorréia e otite média crónica supurativa (OMCS) são limitados entre as crian-
ças na África. Os agentes bacterianos comuns no nosso estudo são similares àqueles de outros es-
tudos na África. A prevalência da otorréia persistente nos estudos aparece suficientemente alta a 
atingir a magnitude de uma preocupação de saúde pública. 
II. A OM concomitante no MB é relativamente comum (12%) em Angola, apresentando um quadro 
e evolução clínica complexa. Estas crianças apresentam um grande risco para doença complicada 
ou morte. Aquelas com otorréia são provavelmente provenientes de condições precárias, havendo 
comumente enfermidades ocultas e devem ser testados para VIH.
III. A perda auditiva ocorre frequentemente entre os sobreviventes da MB em Angola, com uma asso-
ciação diferenciada entre as etiologias bacterianas e a extensão da perda auditiva. A idade ressalta 
como um factor importante, contribuindo à consequência auditiva. Além disso, a S. pneumoniae 
parece particularmente destrutivo às crianças jovens, enquanto a N. meningitidis é associada com 
perda auditiva mais suave. 
IV. Uma RATC única ou repetitiva não prevê consequencias negativas em Angola. Latências tardias de 
ondas III ou V ou latências intervalos interpicos associadas com uma maior taxa de mortalidade ou 
sequela neurológica severa, mas não foram relevantes como ferramenta prática prognóstica. A MB 
infantil afecta o tempo de conducção neural no caminho do tronco cerebral.
Baseado neste estudo, recomenda-se inclusão de cri-
anças menores de 5 anos  nas pesquisas populacio-
nais futuras sobre a OM entre crianças africanas. Es-
tudos longitudinais de MB de grupo de países pobres 
servirá para esclarescer a interacção entre os vários 
factores de risco, a evolução e prognose de doenças 
e os verdadeiros efeitos de longo prazo da OMCS. 
Além disto, necessita-se de  ferramentas diagnósti-
cas confiáveis e utilizáveis para perda auditiva em 
condições carentes para planejar e ajustar os serviços 
de rehabilitação. Ademais, necessita-se ainda ferra-
mentas clínicamente relevantes para prognósticas às 
condições carentes. 
Baseado em perspectivas mais amplas, as acções 
futuras devem focar nas estratégias preventivas da 
OM e MB, incluindo, entre outros, a imunizações 
infantís otimizadas, melhoramentos higiênicos, de 
saneamento, condições de vida e educação dos pais; 
desenvolvimento de estratégias de saúde pública ao 
alcance da população à nível de communidade e per-
mitir a identificação prévia de doenças; melhoran-
do-se o acesso ao tratamento, suportes e tecnologias 
auditivas; e apoiando-se a reabilitação e educação de 
crianças desabilitados. 
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